Document:

Prepared by R.R. Donnelley Financial -- EX-4.2

 Exhibit 4.2 
 AMENDED AND RESTATED 
 INVESTORS’ RIGHTS AGREEMENT 

GOOD TECHNOLOGY CORPORATION 
 FEBRUARY 22, 2014 

 TABLE OF CONTENTS 

 

									
	 	 	 	 	 	  	Page	 
			
	1.	 	 Registration Rights
	  	 	1	  
				
		 	1.1	 	 Definitions
	  	 	1	  
		 	1.2	 	 Company Registration
	  	 	3	  
		 	1.3	 	 Obligations of the Company
	  	 	4	  
		 	1.4	 	 Furnish Information
	  	 	6	  
		 	1.5	 	 Expenses of Registration
	  	 	7	  
		 	1.6	 	 Underwriting Requirements
	  	 	7	  
		 	1.7	 	 Delay of Registration
	  	 	8	  
		 	1.8	 	 Indemnification
	  	 	8	  
		 	1.9	 	 Reports Under Securities Exchange Act of 1934
	  	 	10	  
		 	1.10	 	 Form S-3 Registration
	  	 	11	  
		 	1.11	 	 Assignment of Registration Rights
	  	 	12	  
		 	1.12	 	 “Market Stand-Off” Agreement
	  	 	12	  
		 	1.13	 	 Request for Registration
	  	 	13	  
		 	1.14	 	 Termination of Registration Rights
	  	 	15	  
		 	1.15	 	 Limitations on Subsequent Registration Rights
	  	 	16	  
			
	2.	 	 Covenants of the Company
	  	 	16	  
				
		 	2.1	 	 Delivery of Financial Statements
	  	 	16	  
		 	2.2	 	 Inspection
	  	 	18	  
		 	2.3	 	 Termination of Information and Inspection Covenants
	  	 	18	  
		 	2.4	 	 Right of First Offer
	  	 	18	  
		 	2.5	 	 Waivers
	  	 	19	  
		 	2.6	 	 Indemnification Agreements
	  	 	19	  
		 	2.7	 	 D&O Insurance
	  	 	20	  
		 	2.8	 	 Board Expenses
	  	 	20	  
		 	2.9	 	 Termination of Rights
	  	 	20	  
			
	3.	 	 Miscellaneous
	  	 	20	  
				
		 	3.1	 	 Successors and Assigns
	  	 	20	  
		 	3.2	 	 Governing Law
	  	 	20	  
		 	3.3	 	 Counterparts
	  	 	20	  
		 	3.4	 	 Titles and Subtitles
	  	 	20	  
		 	3.5	 	 Notices
	  	 	20	  
		 	3.6	 	 Expenses
	  	 	21	  
		 	3.7	 	 Amendments and Waivers
	  	 	21	  
		 	3.8	 	 Severability
	  	 	21	  
		 	3.9	 	 Aggregation of Stock
	  	 	21	  
		 	3.10	 	 Entire Agreement
	  	 	21	  
		 	3.11	 	 Subsequent Investors
	  	 	22	  
		 	3.12	 	 Arbitration
	  	 	22	  
		 	3.13	 	 Prior Agreement
	  	 	22	  

 AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 
 THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of the 22nd day of February, 2014, by and among Good Technology Corporation, a Delaware
corporation (the “Company”) and the investors listed on Schedule A hereto (the “Investors”). 
 RECITALS 
 WHEREAS, certain existing Investors (the “Existing
Investors”) hold shares of the Company’s capital stock and possess registration rights, information rights, rights of first offer, and other rights pursuant to the Amended and Restated Investors’ Rights Agreement dated as of
April 15, 2013, among the Company and such Existing Investors, as amended (the “Prior Agreement”); 

WHEREAS, the undersigned Existing Investors are, collectively, holders of at least a majority of the outstanding shares of capital stock
that constituted “Registrable Securities” under the Prior Agreement, and, along with the Company, desire to amend and restate the Prior Agreement pursuant to the terms of Section 3.7 thereunder and to agree to forego the registration
rights, information rights, rights of first offer and other rights that the Existing Investors currently hold, and agree to be bound by the rights and obligations provided herein; 

WHEREAS, the Company and certain Investors are parties to that certain Agreement and Plan of Reorganization, by and between the Company,
BoxTone, Inc. (“BoxTone”) and certain other parties thereto, of even date herewith (the “Merger Agreement”), pursuant to which such Investors have agreed to receive shares of the Company’s Common Stock and/or
the Company’s Series C-2 Preferred Stock (the “Series C-2 Preferred Stock”) as consideration for the transactions contemplated by the Merger Agreement; and 

WHEREAS, to induce BoxTone to enter into the Merger Agreement and to add certain former BoxTone stockholders as parties to this
Agreement, the Existing Investors and the Company desire to amend and restate the Prior Agreement; 
 NOW, THEREFORE, in
consideration of the mutual promises and covenants set forth herein, the parties hereto hereby agree that the Prior Agreement shall be superseded, amended and restated and shall read in its entirety as follows: 

1. Registration Rights. The Company covenants and agrees as follows: 

1.1 Definitions. For purposes of this Section 1: 

(a) The term “Act” means the Securities Act of 1933, as amended. 

 (b) The term “Affiliate” means, with respect to any stockholder, a
partner, retired partner, member, or retired member of such stockholder (including spouses, ancestors, lineal descendants and siblings of such persons who acquire Registrable Securities by gift, will or intestate succession) and any corporation,
partnership, limited liability company or other legal entity that controls, is controlled by, or is under common control with such stockholder. 
 (c) The term “Form S-3” means such form under the Act as in effect on the date hereof or any registration form under the Act subsequently adopted by the SEC which permits inclusion or
incorporation of substantial information by reference to other documents filed by the Company with the SEC. 
 (d) The term
“Holder” means any person owning or having the right to acquire Registrable Securities or any assignee thereof in accordance with Section 1.11 hereof. 
 (e) The term “Liquidation Event” shall have the same meaning as set forth in the Restated Certificate (as defined below). 

(f) The term “Major Holder” shall mean (i) any Holder of Series B-1 Preferred Stock, Series B-2 Preferred Stock or
Series B-3 Preferred Stock who, together with such Holder’s Affiliates, holds not less than 5,000,000 shares of Registrable Securities (adjusted to reflect stock splits, stock dividends, combinations, consolidations, recapitalizations and the
like), (ii) until less than 1,827,040 shares of Series C-1 Preferred Stock (adjusted to reflect stock splits, stock dividends, combinations, consolidations, recapitalizations and the like) remain outstanding, any Holder of Series C-1 Preferred
Stock and (iii) until less than 1,827,040 shares of Series C-2 Preferred Stock (adjusted to reflect stock splits, stock dividends, combinations, consolidations, recapitalizations and the like) remain outstanding, any Holder of Series C-2
Preferred Stock. 
 (g) The term “Information Rights Holder” shall mean (i) any Investor who, together
with such Investor’s Affiliates, owns or has the right to acquire at least 1,827,040 shares of Series C-1 Preferred Stock (adjusted to reflect stock splits, stock dividends, combinations, consolidations, recapitalizations and the like),
(ii) any Investor who, together with such Investor’s Affiliates, owns or has the right to acquire at least 3,000,000 shares of Series C-2 Preferred Stock (adjusted to reflect stock splits, stock dividends, combinations, consolidations,
recapitalizations and the like) or (iii) any Existing Investor who, together with such Existing Investor’s Affiliates, holds not less than 1,000,000 shares of Registrable Securities (adjusted to reflect stock splits, stock dividends,
combinations, consolidations, recapitalizations and the like). 
 (h) The term “1934 Act” shall mean the
Securities Exchange Act of 1934, as amended. 

  
 2 

 (i) The term “Qualified Public Offering” shall mean a firmly underwritten,
initial public offering of shares of the Common Stock of the Company; provided, however, that (i) the gross proceeds of such offering are at least $50,000,000 and (ii) the Common Stock of the Company is listed on a nationally recognized
exchange. 
 (j) The term “register,” “registered,” and “registration” refer to a registration
effected by preparing and filing a registration statement or similar document in compliance with the Act, and the declaration or ordering of effectiveness of such registration statement or document. 

(k) The term “Registrable Securities” means (i) the Common Stock issuable or issued upon conversion of the
Company’s Preferred Stock held by Holders and (ii) any Common Stock of the Company issued as (or issuable upon the conversion or exercise of any warrant, right or other security which is issued as) a dividend or other distribution with
respect to, or in exchange for or in replacement of the shares referenced in (i) above, excluding in all cases, however, any Registrable Securities sold by a person in a transaction in which his rights under this Section 1 are not
assigned; provided, however, that Registrable Securities shall not include any shares of Common Stock for which registration rights have terminated pursuant to Section 1.14 of this Agreement or which have been sold in a private transaction in
which the transferor’s rights under this Agreement are not validly assigned in accordance with this Agreement. 
 (l) The
number of shares of “Registrable Securities then outstanding” shall be determined by the number of shares of Common Stock outstanding which are, and the number of shares of Common Stock issuable pursuant to then exercisable or
convertible securities which are, Registrable Securities. 
 (m) The term “Restated Certificate” means the
Company’s Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on or about the date hereof. 
 (n) The term “SEC” shall mean the Securities and Exchange Commission. 
 (o) The term “SEC Rule 145” shall mean Rule 145 promulgated by the SEC under the Act. 
 1.2 Company Registration.
 (a) If (but without any obligation to do so)
the Company proposes to register (including for this purpose a registration effected by the Company for stockholders other than the Holders) any of its stock or other securities under the Act in connection with the public offering of such securities
solely for cash (other than a registration relating solely to the sale of securities to participants in a Company stock plan, a registration relating to an SEC Rule 145 transaction, a registration on any form which does not include

  
 3 

 
substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities or a registration in which the only Common Stock
being registered is Common Stock issuable upon conversion of debt securities which are also being registered), the Company shall, at such time, promptly give each Holder written notice of such registration. Upon the written request of each Holder
given within twenty (20) days after mailing of such notice by the Company in accordance with Section 3.5, the Company shall, subject to the provisions of Section 1.6, cause to be registered under the Act all of the Registrable
Securities that each such Holder has requested to be registered. 
 (b) Right to Terminate Registration. The Company
shall have the right to terminate or withdraw any registration initiated by it under this Section 1.2 prior to the effectiveness of such registration whether or not any Holder has elected to include securities in such registration. The expenses
of such withdrawn registration shall be borne by the Company in accordance with Section 1.5 hereof. 
 1.3 Obligations
of the Company. Whenever required under this Section 1 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 

(a) Prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its best efforts to cause
such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement continuously effective for a period equal to the lesser of one
hundred twenty (120) days or until the distribution contemplated in the registration statement has been completed; provided, however, that (i) such 120-day period shall be extended for a period of time equal to the period the Holder
refrains from selling any securities included in such registration at the request of an underwriter of Common Stock (or other securities) of the Company; and (ii) in the case of any registration of Registrable Securities on Form S-3 which are
intended to be offered on a continuous or delayed basis, such 120-day period shall be extended, if necessary, to keep the registration statement effective until all such Registrable Securities are sold, provided that Rule 415, or any successor
rule under the Act, permits an offering on a continuous or delayed basis, and provided, further, that applicable rules under the Act governing the obligation to file a post-effective amendment permit, in lieu of filing a post-effective amendment
which (A) includes any prospectus required by Section 10(a)(3) of the Act or (B) reflects facts or events representing a material or fundamental change in the information set forth in the registration statement, the incorporation by
reference of information required to be included in (I) and (H) above to be contained in periodic reports filed pursuant to Section 13 or 15(d) of the 1934 Act in the registration statement. 

(b) Prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection
with such registration statement as may be necessary to comply with the provisions of the Act with respect to the disposition of all securities covered by such registration statement. 

  
 4 

 (c) Furnish to the Holders such numbers of copies of a prospectus, including a preliminary
prospectus, in conformity with the requirements of the Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them. 

(d) Use its best efforts to register and qualify the securities covered by such registration statement under such other securities or
Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders; provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service
of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the Act. 
 (e) In the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing underwriter of such offering.
Each Holder participating in such underwriting shall also enter into and perform its obligations under such an agreement. 

(f) Immediately notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus
relating thereto is required to be delivered under the Act of the happening of any event as a result of which the registration statement, the prospectus included in such registration statement, or any document incorporated or deemed to be
incorporated therein by reference includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then
existing, and at the written request of any such Holder promptly prepare and furnish to such Holder a reasonable number of copies of a post-effective amendment to the registration statement or a supplement to the prospectus or any document
incorporated or deemed incorporated therein by reference so that, as thereafter delivered to the purchasers of the Registrable Securities being sold thereunder, such registration statement or prospectus will not contain an untrue statement of
material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. 

(g) Cause all such Registrable Securities registered pursuant to this Section 1 to be listed on each securities exchange on which
similar securities issued by the Company are then listed. 
 (h) Provide a transfer agent and registrar for all Registrable
Securities registered pursuant hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration. 
 (i) Use its best efforts to furnish, at the request of any Holder requesting registration of Registrable Securities pursuant to this Section 1, on the date that such Registrable Securities are
delivered to the underwriters for sale in connection with a registration pursuant to this Section 1, if such securities are being sold through underwriters, or, if such 

  
 5 

 
securities are not being sold through underwriters, on the date that the registration statement with respect to such securities becomes effective, (i) an opinion, dated such date, of counsel
representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters, if any, and to the Holders requesting registration of
Registrable Securities and (ii) a letter dated such date, from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an
underwritten public offering, addressed to the underwriters, if any, and to the Holders requesting registration of Registrable Securities. 
 (j) Make available for inspection by each Holder, any underwriter participating in any distribution pursuant to such registration statement, and any attorney, accountant or other agent retained by such
Holder or underwriter, reasonable access to all financial and other records, pertinent corporate documents and properties of the Company, as such parties may reasonably request, and cause the Company’s officers, directors and employees to
supply all information reasonably requested by any such Holder. 
 (k) Comply with all applicable rules and regulations of the
SEC, and make available to its security holders, as soon as reasonably practicable but no later than fifteen (15) months after the effective date of the registration statement, an earnings statement covering a period of twelve (12) months
beginning after the effective date of the registration statement, in a manner which satisfies the provisions of Section 11(a) of the Act and Rule 158 thereunder. 
 (l) Use its best efforts to keep a Holder’s counsel advised as to the initiation and progress of any registration under this Section 1, upon the reasonable request in writing by any such
Holder’s counsel. 
 1.4 Furnish Information.

(a) It shall be a condition precedent to the obligations of the Company to take any action pursuant to this Section 1 with respect
to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such securities as shall be
required by the Act to effect the registration of such Holder’s Registrable Securities. 
 (b) The Company shall have no
obligation with respect to any registration requested pursuant to Section 1.10 or Section 1.13 if, due to the operation of subsection 1.4(a), the number of shares or the anticipated aggregate offering price of the Registrable Securities to
be included in the registration does not equal or exceed the number of shares or the anticipated aggregate offering price required to originally trigger the Company’s obligation to initiate such registration as specified in Section 1.10 or
Section 1.13, as applicable. 

  
 6 

 1.5 Expenses of Registration. The Company shall bear and pay all expenses
incurred in connection with any registration, filing or qualification of Registrable Securities with respect to the registrations pursuant to Section 1.2, Section 1.10 and Section 1.13 for each Holder (which rights may be assigned as
provided in Section 1.11), including (without limitation) all registration, filing, and qualification fees, printers and accounting fees relating or apportionable thereto, and the fees and disbursements of counsel for the Company and one
counsel for the selling Holders selected by them in an amount not to exceed $20,000, but excluding underwriting discounts and commissions relating to Registrable Securities. Notwithstanding the foregoing, the Company shall not be required to pay for
any expenses of any registration proceeding begun pursuant to Section 1.10 or Section 1.13 if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in
which case all participating Holders shall bear such expenses pro rata based on the number of Registrable Securities that were to be included in the withdrawn registration), provided, however that if at the time of such withdrawal, the Holders have
learned of a material adverse change in the condition, business, or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with reasonable promptness following disclosure by the Company of
such material adverse change, then the Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to Section 1.10 or Section 1.13 and shall not be deemed to have requested a registration. 

1.6 Underwriting Requirements. In connection with any offering involving an underwriting of shares of the Company’s
capital stock, the Company shall not be required under Section 1.2 to include any of the Holders’ securities in such underwriting unless they accept the terms of the underwriting as agreed upon between the Company and the underwriters
selected by it (or by other persons entitled to select the underwriters), and then, with respect to a registration under Section 1.2, only in such quantity as the underwriters determine in their sole discretion will not jeopardize the success
of the offering by the Company. If the total amount of securities, including Registrable Securities, requested by stockholders to be included in such registration under Section 1.2 exceeds the amount of securities sold other than by the Company
that the underwriters determine in their sole discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities, which the
underwriters determine in their sole discretion will not jeopardize the success of the offering. The Company shall so advise all Holders of securities requesting registration, and the number of shares of securities that are entitled to be included
in the registration and underwriting shall be reduced, as follows: (i) first, shares requested to be included by stockholders that do not have registration rights, (ii) second, shares requested to be included by the Holders of Series B-1
Preferred Stock, Series B-2 Preferred Stock or Series B-3 Preferred Stock, and (iii) third, the Registrable Securities. Notwithstanding the foregoing, no such reduction shall reduce the value of the Registrable Securities of the Holders
included in such registration below thirty-three percent (33%) of the total value of securities included in such registration, unless such offering is the initial public offering of the Company’s securities, such registration does not
include shares of any other selling stockholders and the underwriters make the determination described above, in which event any or all of the Registrable Securities of the Holders may be excluded. 

  
 7 

 1.7 Delay of Registration. No Holder shall have any right to obtain or seek an
injunction restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 1. 

1.8 Indemnification. In the event any Registrable Securities are included in a registration statement under this
Section 1: 
 (a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, each of such
Holder’s officers, directors, stockholders and partners, such Holder’s legal counsel and accountants, any underwriter (as defined in the Act) for such Holder and each person, if any, who controls such Holder or underwriter within the
meaning of the Act or the 1934 Act, against any expenses, losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Act, the 1934 Act or other federal or state law or any rule or regulation promulgated
under the Act, insofar as such expenses, losses; claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”):
(i) any untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto and any
document incorporated or deemed incorporated therein by reference, (ii) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, (iii) any
violation or alleged violation by the Company of the Act, the 1934 Act, any state securities law or any rule or regulation promulgated under the Act, the 1934 Act or any state securities law or common law or (iv) a breach of the representations
in the underwriting agreement; and the Company will pay to each such Holder, underwriter, controlling person or other aforementioned person any legal or other expenses reasonably incurred by them in connection with investigating or defending or
settling any such loss, claim, damage, liability, or action as such expenses are incurred; provided, however, that the indemnity agreement contained in this subsection 1.8(a) shall not apply to amounts paid in settlement of any such loss, claim,
damage, liability, or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case for any such loss, claim, damage, liability, or
action to the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such registration by any such Holder, underwriter,
controlling person or other aforementioned person. 
 (b) To the extent permitted by law, each selling Holder will, severally
and not jointly, indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Act, any underwriter, any other
Holder selling securities in such registration statement and any controlling person of any such underwriter or other Holder, against any expenses, losses, claims, damages, or liabilities (joint or several) to which any of the foregoing persons may
become subject, under the Act, the 1934 Act or other federal or state law 

  
 8 

 
or any rule or regulation promulgated under the Act, insofar as such losses, expenses, claims, damages, or liabilities (or actions in respect thereto) arise out of or are based upon any
Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder expressly for use in connection with such registration; and each such
Holder will pay any legal or other expenses reasonably incurred by any person intended to be indemnified pursuant to this subsection 1.8(b), in connection with investigating or defending or settling any such loss, claim, damage, liability, or action
as such expenses are incurred; provided, however, that the indemnity agreement contained in this subsection 1.8(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected
without the consent of the Holders, (which consent shall not be unreasonably withheld); provided, that, in no event shall any indemnity under this subsection 1.8(b), when combined with any amounts paid to such Holder pursuant to Section 1.8(d),
exceed the net proceeds from the offering received by such Holder. 
 (c) Promptly after receipt by an indemnified party under
this Section 1.8 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 1.8, deliver to
the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed,
to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties which may be represented without conflict by one counsel) shall have the right
to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential
differing interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action,
if prejudicial to its ability to defend such action, shall relieve such indemnifying party of liability to the indemnified party under this Section 1.8 to the extent of such prejudice, but the omission so to deliver written notice to the
indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 1.8. 
 (d) If the indemnification provided for in this Section 1.8 is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage
or expense referred to therein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage or
expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other in connection with the statements or omissions that resulted in such loss, liability,
claim, damage or expense as well as any other relevant equitable considerations; provided, that in no event shall any contribution by a Holder under this Section 1.8(d), when combined with any amounts paid by such Holder pursuant to
Section 1.8(b), exceed the net proceeds from the offering received by such Holder. The relative 

  
 9 

 
fault of the indemnifying party and of the indemnified party shall be determined by reference, among other things, to whether the untrue or alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent
such statement or omission. 
 (e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and
contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, as between the Company and the Holders the provisions in this Agreement shall
control. 
 (f) The obligations of the Company and Holders under this Section 1.8 shall survive the completion of any
offering of Registrable Securities in a registration statement under this Section 1, and otherwise. 
 1.9 Reports
Under Securities Exchange Act of 1934. With a view to making available to the Holders the benefits of Rule 144 promulgated under the Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell
securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company agrees to: 

(a) make and keep public information available, as those terms are understood and defined in SEC Rule 144 or any subsequently
adopted rule, at all times after ninety (90) days after the effective date of the first registration statement filed by the Company for the offering of its securities to the general public; 

(b) take such action, including the voluntary registration of its Common Stock under Section 12 of the 1934 Act, as is necessary to
enable the Holders to utilize Form S-3 for the sale of their Registrable Securities, such action to be taken as soon as practicable after the end of the fiscal year in which the first registration statement filed by the Company for the offering of
its securities to the general public is declared effective; 
 (c) file with the SEC in a timely manner all reports and other
documents required of the Company under the Act and the 1934 Act; and 
 (d) furnish to any Holder, so long as the Holder owns
any Registrable Securities, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after ninety (90) days after the effective date of the first
registration statement filed by the Company or after the Company becomes subject to the reporting requirements of the 1934 Act), the Act and the 1934 Act (at any time after it has become subject to such reporting requirements), or that it qualifies
as a registrant whose securities may be resold pursuant to Form S-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and
(iii) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC which permits the selling of any such securities without registration or pursuant to such form. 

  
 10 

 1.10 Form S-3 Registration. In case the Company shall receive from the Holders
of at least ten percent (10%) of the Registrable Securities then outstanding a written request or requests that the Company effect a registration on Form S-3 and any related qualification or compliance with respect to all or a part of the
Registrable Securities owned by such Holder or Holders, the Company will: 
 (a) promptly give written notice of the proposed
registration, and any related qualification or compliance, to all other Holders; and 
 (b) as soon as practicable, effect such
registration and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holder’s or Holders’ Registrable Securities as are specified in such
request, together with all or such portion of the Registrable Securities of any other Holder or Holders joining in such request as are specified in a written request given within 15 days after receipt of such written notice from the Company,
subject, however, to the limitations set forth in Section 1.13(b) if the offering involves an underwriting (which provisions of Section 1.13(b) shall apply to offerings under this Section 1.10); provided, however, that the Company
shall not be obligated to effect any such registration, qualification or compliance, pursuant to this Section 1.10: (1) if Form S-3 is not available for such offering by the Holders; (2) if the Holders, together with the holders of
any other securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at an aggregate price to the public (net of any underwriters’ discounts or commissions) of
less than $3,000,000; (3) if the Company shall furnish to the Holders a certificate signed by the Company’s Chief Executive Officer or Chairman of the Board of Directors of the Company (the “Board”) stating that in the
good faith judgment of the Board, it would be seriously detrimental to the Company and its stockholders for such Form S-3 registration to be effected at such time, in which event the Company shall have the right to defer the filing of the Form S-3
registration statement for a period of not more than ninety (90) days after receipt of the request of the Holder or Holders under this Section 1.10; provided, however, that the Company shall not utilize this right more than once in any
twelve (12) month period; and provided further that the Company shall not register any securities for the account of itself or any other stockholder during such ninety (90) day period (other than a registration relating solely to the sale
of securities of participants in a Company stock plan, a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable
Securities, or a registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered); (4) if the Company has, within the twelve (12) month period
preceding the date of such request, already effected two registrations on Form S-3 for the Holders pursuant to this Section 1.10; or (5) in any particular jurisdiction in which the Company would be required to qualify to do business or to
execute a general consent to service of process in effecting such registration, qualification or compliance, unless the Company is already qualified to do business and subject to service of process in such jurisdiction and except as may be required
under the Act. 

  
 11 

 (c) Subject to the foregoing, the Company shall file a registration statement covering the
Registrable Securities and other securities so requested to be registered as soon as practicable after receipt of the request or requests of the Holders. 
 (d) Any registrations effected pursuant to this Section 1.10 shall not be counted as a registration effected pursuant to Section 1.13. 

(e) A registration shall not constitute a registration on Form S-3 until it has become effective and remains continuously effective for
the period of the distribution contemplated thereby (determined as provided in Section 1.3 hereof); provided, however, that a registration shall not constitute a registration on Form S-3 if (x) after such registration has become effective,
such registration of the related offer, sale or distribution of Registrable Securities thereunder is interfered with by any stop order, injunction or other order or requirement of the SEC or other governmental agency or court for any reason not
attributable to the Holders initiating the registration hereunder and such interference is not thereafter eliminated or (y) the conditions specified in the underwriting agreement, if any, entered into in connection with such registration are
not satisfied or waived, other than by reason of a failure by the Holders initiating the registrations hereunder. 
 1.11
Assignment of Registration Rights. The rights to cause the Company to register Registrable Securities pursuant to this Section 1 may be assigned (but only with all related obligations) by a Holder to a transferee or assignee of such
securities, provided: (a) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are
being assigned; (b) that such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement, including without limitation the provisions of Section 1.12 below; (c) that such
transferee or assignee (i) is an Affiliate, (ii) is a family member or trust for the benefit of any individual holder, or (iii) acquires at least 1,000,000 shares (adjusted to reflect stock splits, stock dividends, combinations,
consolidations, recapitalizations and the like) of Registrable Securities (provided that such number threshold may be reduced in any particular instance with the written consent of the Company); and (d) such assignment shall be effective only
if immediately following such transfer the further disposition of such securities by the transferee or assignee is restricted under the Act. For the purposes of determining the number of shares of Registrable Securities held by a transferee or
assignee, the holdings of Affiliates shall be aggregated together. 
 1.12 “Market Stand-Off”
Agreement. Each Investor hereby agrees that, during the period of duration specified by the Company and the managing underwriter of Common Stock or other securities of the Company, following the effective date of a registration statement of
the Company filed under the Act, it shall not, to the extent requested by the Company and such underwriter, (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to 

  
 12 

 
purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (whether such
shares or any such securities are now owned by the undersigned or are hereafter acquired), or (2) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the
Common Stock, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise (other than to donees who agree to be similarly bound) except
Common Stock included in such registration; provided, however, that: 
 (a) such agreement shall be applicable only to the
first such registration statement of the Company which covers Common Stock (or other securities) to be sold on its behalf to the public in an underwritten offering; 
 (b) all executive officers and directors of the Company and holders of at least one percent (1%) of the Company’s securities enter into similar agreements; 

(c) such market stand-off time period shall (i) not exceed 180 days, (ii) not apply to any securities acquired in a subject
offering, and (iii) not apply to any securities acquired in the open market following such offering; and 
 (d) no
executive officer, director, holder of at least one percent (1%) of the Company’s securities or holder of Preferred Stock may be released from any obligation under the provisions of this Section 1.12 or any similar agreement between
such person and the Company and/or an underwriter unless all holders of Preferred Stock are also released with respect to such shares on a pro rata basis based on the number of shares of Preferred stock held by such holder. 

In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the Common Stock of each
Investor (and the shares or securities of every other person subject to the foregoing restriction) until the end of such period. 
 Notwithstanding the foregoing, the obligations described in this Section 1.12 shall not apply to a registration relating solely to employee benefit plans on Form S-1 or Form S-8 or similar forms
which may be promulgated in the future, or a registration relating solely to a Commission Rule 145 transaction on Form S-4 or similar forms which may be promulgated in the future. 

1.13 Request for Registration.
 (a) Subject to the conditions of this Section 1.13, if the Company shall receive at any time after the earlier of (i) October 15, 2014 or (ii) six (6) months after the effective date
of a Qualified Public Offering, a written request from the holders of twenty percent (20%) or more of the Registrable Securities then outstanding (the “Initiating Holders”) that the Company file a registration statement under
the Act covering the registration of Registrable Securities with an anticipated aggregate offering price of at least $15,000,000, 

  
 13 

 
then the Company shall, within twenty (20) days of the receipt thereof, give written notice of such request to all Holders, and subject to the limitations of this Section 1.13, use
commercially reasonable efforts to effect, as soon as practicable, the registration under the Act of all Registrable Securities that the Holders request to be registered in a written request received by the Company within twenty (20) days of
the mailing of the Company’s notice pursuant to this Section 1.13(a); provided, however, that, simultaneously with the filing of such Registration Statement, the Initiating Holders must vote to convert all of the issued and outstanding
shares of Preferred Stock of the Company to Common Stock (or, in the alternative, must elect to convert such Initiating Holder’s shares to Common Stock), as provided in the Restated Certificate (provided that any such election may be contingent
on and subject to the closing of any such offering). 
 (b) If the Initiating Holders intend to distribute the Registrable
Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 1.13 and the Company shall include such information in the written notice referred to in
Section 1.13(a). In such event the right of any Holder to include its Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s
Registrable Securities in the underwriting (unless otherwise mutually agreed by a majority in interest of the Initiating Holders and such Holder) to the extent provided herein. All Holders proposing to distribute their securities through such
underwriting shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting by the Company (which underwriter or underwriters shall be reasonably acceptable to a majority in interest
of the Initiating Holders). Notwithstanding any other provision of this Section 1.13, if the underwriter advises the Company that marketing factors require a limitation of the number of securities underwritten (including Registrable
Securities), then the Company shall so advise all Holders of Registrable Securities that would otherwise be underwritten pursuant hereto, and the number of shares that may be included in the underwriting shall be allocated to the Holders of such
Registrable Securities on a pro rata basis based on the number of Registrable Securities held by all such Holders (including the Initiating Holders). In no event shall any Registrable Securities be excluded from such underwriting unless all other
securities are first excluded. Any Registrable Securities excluded or withdrawn from such underwriting shall be withdrawn from the registration. 
 (c) The Company shall not be required to effect a registration pursuant to this Section 1.13: 
 (i) in any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting such registration, unless the Company is already subject to
service in such jurisdiction and except as may be required under the Act; or 

  
 14 

 (ii) after the Company has initiated two such registrations pursuant to this
Section 1.13, and such registrations have been declared or ordered effective; or 
 (iii) during the period starting with
the date forty-five (45) days prior to the Company’s good faith estimate of the date of the filing of, and ending on a date one hundred eighty (180) days following the effective date of, a Company-initiated registration subject to
Section 1.2 hereof, provided that the Company delivers a certificate signed by the Company’s Chief Executive Officer within thirty (30) days of the written request for registration stating the same and the Company is actively
employing in good faith all reasonable efforts to cause such registration statement to become effective; or 
 (iv) if the
Company has already effected a registration under this Section 1.13 within the previous twelve (12) months; or 
 (v)
if the Initiating Holders propose to dispose of Registrable Securities that may be registered on Form S-3 pursuant to Section 1.10 hereof; or 
 (vi) if the Company shall furnish to Holders requesting a registration statement pursuant to this Section 1.13, a certificate signed by the Company’s Chief Executive Officer or Chairman of the
Board stating that in the good faith judgment of the Board, it would be seriously detrimental to the Company and its stockholders for such registration statement to be effected at such time, in which event the Company shall have the right to defer
such filing for a period of not more than ninety (90) days after receipt of the request of the Initiating Holders, provided that such right to delay a request shall be exercised by the Company not more than once in any twelve (12)-month period;
and provided further that the Company shall not register any securities for the account of itself or any other stockholder during such ninety (90) day period (other than a registration relating solely to the sale of securities of participants
in a Company stock plan, a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities, or a registration in which
the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered). 
 1.14 Termination of Registration Rights. The right of any Holder to request registration or inclusion in any registration pursuant to Section 1.2, Section 1.10 and Section 1.13
shall terminate upon the earlier of (a) five (5) years following the consummation of the first firmly underwritten public offering of shares of Common Stock of the Company registered under the Act pursuant to a registration statement on
Form S-1, (b) consummation of a Liquidation Event, or (c) as to any Holder, such earlier time at which all Registrable Securities held by such Holder (and any Affiliate of the Holder with whom such Holder must aggregate its sales under
Rule 144) can be sold in any three (3)-month period without registration in compliance with Rule 144 of the Act, provided that the Company give the Holder fifteen (15) days written notice of such termination of rights. 

  
 15 

 1.15 Limitations on Subsequent Registration Rights.

(a) From and after the date of this Agreement, the Company shall not, without the prior written consent of the Holders of a majority of
the Registrable Securities then outstanding, enter into any agreement with any holder or prospective holder of any securities of the Company which would (i) allow such holder or prospective holder (A) to include any of the Company’s
securities in any registration filed under Section 1.13 hereof, unless under the terms of such agreement, such holder or prospective holder may include such securities in any such registration only to the extent that the inclusion of its or his
securities will not reduce the amount of Registrable Securities of the Holders which is included in the registration or (B) to make a demand registration which could result in a registration statement being declared effective prior to the
earlier of either of the dates set forth in Section 1.13(a) or within one hundred twenty (120) days of the effective date of any registration effected pursuant to Section 1.13; or (ii) give such holder or prospective holder any
“piggyback” registration rights superior to those provided to the holders by Section 1.2 of this Agreement. 

(b) From and after the date of the date of this Agreement, no future registration rights may be granted without the consent of a
majority of the Holders, unless such rights are subordinate to those of the Holders. 
 (c) Notwithstanding subsections
(a) and (b) above, if, after the date hereof, (1) a majority of the Board approves the grant of registration rights substantially identical to the registration rights contained in this Section 1 to a person (a “Future
Party”) in connection with Common Stock (or stock or other securities convertible into or exercisable for, either directly or indirectly, Common Stock) then held or issuable to such Future Party and (2) the Company receives the written
consent of the Holders of a majority of the Registrable Securities approving the grant of registration rights to such Future Party, then such Future Party shall become a party hereto and shall be included within the definition of “Holder”
hereof, and the Common Stock issued or issuable, directly or indirectly, to such party shall, to the extent and amounts approved, be included within the definition of “Registrable Securities” upon the execution of a counterpart signature
page hereto by such Future Party. 
 2. Covenants of the Company.

2.1 Delivery of Financial Statements. Except as provided in Section 2.1(f), the Company shall deliver to each
Information Rights Holder: 
 (a) as soon as practicable, but in any event within one hundred twenty (120) days after the
end of each fiscal year of the Company, an income statement for such fiscal year, a balance sheet of the Company and statement of stockholder’s equity as of the end of such year, and a statement of cash flows for such year, such year-end
financial reports to be in reasonable detail, prepared in accordance with generally accepted accounting principles (“GAAP”), and audited and certified by independent public accountants of nationally recognized standing selected by
the Company; 

  
 16 

 (b) as soon as practicable, but in any event within sixty (60) days after the end of
each of the first three (3) quarters of each fiscal year of the Company, an unaudited profit or loss statement, statement of cash flows for such fiscal quarter and an unaudited balance sheet as of the end of such fiscal quarter; 

(c) as soon as practicable, but in any event within thirty (30) days of the beginning of each fiscal year (or on such later date as
an annual operating plan, a statement of financial projections or a projected budget shall have been approved by the Board), an annual operating plan, a statement of financial projections and a projected budget approved by the Board for such fiscal
year; 
 (d) with respect to the financial statements called for in subsection (b) of this Section 2.1, an instrument
executed by the Chief Financial Officer or President of the Company certifying that such financials were prepared in accordance with GAAP consistently applied with prior practice for earlier periods (with the exception of footnotes that may be
required by GAAP) and fairly present the financial condition of the Company and its results of operation for the period specified, subject to year-end audit adjustment; and 
 (e) such other information relating to the financial condition, business, prospects or corporate affairs of the Company as the Information Rights Holder or any assignee of the Information Rights Holder
may from time to time request; provided, however, that the Company shall not be obligated under this subsection (e) to provide information which it deems in good faith to be a trade secret or similar confidential information. In addition, the
Company shall not be obligated under this subsection (e) or any other subsection of Section 2.1 to provide information to investors who are deemed, in the good faith of the Board, to be direct competitors of the Company. Each Holder
acknowledges that the information received by them pursuant to this Agreement is confidential and for its use only, and each Holder will not trade on the basis of such confidential information nor use such confidential information in any way in
violation of the Exchange Act or reproduce, disclose or disseminate such information to any other person (other than the Holder’s employees or agents having a need to know the contents of such information, and its attorneys), except in
connection with the exercise of rights under this Agreement, unless the Company has made such information available to the public generally. 
 (f) Notwithstanding anything to the contrary herein, the Company shall not be obligated under this Agreement (including under Sections 2.1(c), 2.1(e) or 2.2 hereof) to provide financial projections,
projected budgets or other forward-looking information (collectively, “Projections”) to any holder of Series B-2 Preferred Stock or Series B-3 Preferred Stock, unless both (i) such holder of Series B-2 Preferred Stock or Series
B-3 Preferred Stock obtains a right to receive such Projections in his, her or its capacity as an Information Rights Holder or otherwise and (ii) regardless of the existence of any such contractual right, the Company actually delivers any
Projections to any holder of Series B-1 Preferred Stock that is a party to this Agreement, other than parties entitled to appoint members to the Board and other than parties with Board observer rights. 

  
 17 

 2.2 Inspection. The Company shall permit each Information Rights Holder, at
such Information Rights Holder’s expense, to visit and inspect the Company’s properties, to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with its officers, all at such reasonable
times as may be requested by the Information Rights Holder; provided, however, that the Company shall not be obligated pursuant to this Section 2.2 to provide access to any information which the Board reasonably considers to be a trade secret
or similar confidential information. In addition, the Company shall not be obligated under this Section 2.2 to provide information to investors who are deemed, in the good faith of the Board, to be direct competitors of the Company. 

2.3 Termination of Information and Inspection Covenants. The covenants set forth in Sections 2.1 and 2.2 shall
terminate as to the Information Rights Holders and be of no further force or effect when the sale of securities pursuant to a registration statement filed by the Company under the Act in connection with the firm commitment underwritten offering of
its securities to the general public is consummated or when the Company first becomes subject to the periodic reporting requirements of Sections 12(g) or 15(d) of the 1934 Act, whichever event shall first occur. 

2.4 Right of First Offer. Subject to the terms and conditions specified in this Section 2.4, the Company hereby grants
to each Major Holder a right of first offer with respect to future sales by the Company of its Shares (as hereinafter defined). For purposes of this Section 2.4, a Major Holder includes Affiliates of a Major Holder. A Major Holder shall be
entitled to apportion the right of first offer hereby granted it among itself and its Affiliates in such proportions as it deems appropriate. 
 Each time the Company proposes to offer any shares of, or securities directly or indirectly convertible into or exercisable for any shares of, any class of its capital stock (the
“Shares”), the Company shall first make an offering of such Shares to each Major Holder in accordance with the following provisions: 
 (a) The Company shall deliver a notice by certified mail (the “Notice”) to the Major Holders stating (i) its bona fide intention to offer such Shares, (ii) the number of such
Shares to be offered, and (iii) the price and terms upon which it proposes to offer such Shares. 
 (b) Within twenty
(20) calendar days after receipt of the Notice, the Major Holder may elect to purchase or obtain, at the price and on the terms specified in the Notice, up to that portion of such Shares which equals the proportion that the number of shares of
Common Stock issued and held, or issuable upon conversion of the Preferred Stock then held by such Major Holder bears to the total number of shares of Common Stock of the Company then outstanding (assuming full conversion and exercise of all
convertible or exercisable securities) (the Major Holder’s “Pro Rata Share”). The Company shall promptly, in writing, inform each Major Investor that elects to purchase all the shares available to it (a
“Fully-Exercising Investor”) of any other Major Investor’s failure to do likewise. During the ten (10) day period commencing after such information is given, each Fully-Exercising Investor may elect to purchase its Pro
Rata Share of the Shares for which Major Investors were entitled to subscribe but which were not subscribed for by the Major Investors. 

  
 18 

 (c) If all Shares that Major Holders are entitled to obtain pursuant to subsection 2.4(b)
are not elected to be obtained as provided in Subsection 2.4(b) hereof, the Company may, during the 60-day period following the expiration of the period provided in Subsection 2.4(b) hereof, offer the remaining unsubscribed portion of such Shares to
any person or persons at a price not less than, and upon terms no more favorable to the offeree than those specified in the Notice. If the Company does not enter into an agreement for the sale of the Shares within such period, or if such agreement
is not consummated within 30 days of the execution thereof, the right provided hereunder shall be deemed to be revived and such Shares shall not be offered unless first reoffered to the Major Holders in accordance herewith. 

(d) The right of first offer in this Section 2.4 shall not be applicable (i) to the issuance or sale of securities to
employees, consultants or directors of the Company directly or pursuant to a stock option plan or restricted stock plan approved by the Board (including at least three Preferred Directors, as such term is defined in the Restated Certificate),
(ii) to or after consummation of a Qualified Public Offering, (iii) to the issuance of securities pursuant to the conversion or exercise of convertible or exercisable securities or in connection with a stock split, recapitalization, stock
dividend or other ratable distribution of property or similar transaction approved by the Board (including at least three Preferred Directors), (iv) to the issuance of securities in connection with equipment leasing arrangements, bank
financings, business acquisitions or mergers, joint ventures, licensing arrangements, research and development activity, arrangements regarding the distribution or manufacture of the Company’s products or services or other partnering
arrangements which are not primarily for equity financing purposes and are approved by the Board (including at least three Preferred Directors), (v) to any securities of the Company outstanding as of the date hereof or securities issued in
connection with the exercise or conversion thereof and (vi) to the issuance of securities pursuant to that certain Agreement and Plan of Reorganization by and among the Company, BoxTone and certain other parties thereto, dated on or about the
date of this Agreement. 
 (e) The right of first offer set forth in this Section 2.4 may only be assigned or transferred
in connection with a transfer that complies with the requirements of Section 1.11 of this Agreement. 
 2.5
Waivers. Each of the undersigned Existing Investors (on their own behalf and on behalf of all parties hereto) hereby irrevocably waives the right of first offer set forth in Section 2.4 of the Prior Agreement, and all related notice
periods or notice rights, with respect to the issuance of Series C-1 Preferred Stock pursuant to the Purchase Agreement. 

2.6 Indemnification Agreements. The Company shall enter into the Company’s standard form of indemnification agreement
with each member of the Board promptly after each such member’s appointment to the Board. 

  
 19 

 2.7 D&O Insurance. The Company shall maintain after the Closing (as defined
in the Purchase Agreement) Director and Officer Insurance in an appropriate amount as determined by the Board. 
 2.8 Board
Expenses. The Company shall reimburse each non-employee member of the Board for all reasonable out-of-pocket expenses, including, but not limited to, travel and lodging for attending meetings of the Board (or committees thereof). Such
reimbursement shall be paid within thirty (30) days of submission of written request for reimbursement providing reasonable detail as to the expenses for which reimbursement is sought. 

2.9 Termination of Rights. The covenants set forth in Section 2.4, Section 2.6 and Section 2.7 shall
terminate and be of no further force and effect immediately prior to the earlier of (a) sale of securities pursuant to a registration statement filed by the Company under the Act in connection with the firm commitment underwritten offering of
its securities to the general public and (b) consummation of a Liquidation Event. 
 3. Miscellaneous.

3.1 Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to
the benefit of and be binding upon the respective successors and assigns of the parties (including transferees of any shares of Registrable Securities). Nothing in this Agreement, express or implied, is intended to confer upon any party other than
the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 

3.2 Governing Law. This Agreement shall be governed by and construed under the laws of the State of California as applied to
agreements among California residents entered into and to be performed entirely within California. 
 3.3
Counterparts. This Agreement may be executed in two or more counterparts, including counterparts transmitted by facsimile, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 3.4 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are
not to be considered in construing or interpreting this Agreement. 
 3.5 Notices. All notices and other
communications given or made pursuant hereto shall be in writing and shall be deemed effectively given: (i) upon personal delivery to the party to be notified, (ii) when sent by confirmed electronic mail or facsimile if sent during normal
business hours of the recipient; if not, then on the next business day, (iii) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one (1) day after deposit with
a nationally recognized overnight courier, 

  
 20 

 
specifying next day delivery, with written verification of receipt. All communications shall be sent to the respective parties at the addresses set forth on the signature pages attached hereto
(or at such other addresses as shall be specified by notice given in accordance with this Section 3.5). 
 3.6
Expenses. If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any
other relief to which such party may be entitled. 
 3.7 Amendments and Waivers. Any term of this Agreement may be
amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) with the written consent of the Company and holders of a majority of the Registrable
Securities then outstanding; provided, however, that in the event that such amendment or waiver adversely affects the obligations or rights of any Investor who owns Series C-1 Preferred Stock in a different manner than the other Major Holders,
such amendment or waiver shall also require the written consent of such affected Investor who owns Series C-1 Preferred Stock; provided, further, that in the event that such amendment or waiver adversely affects the obligations or rights of the
holders of shares of Series C-2 Preferred Stock in a different manner than the other Major Holders, such amendment or waiver shall also require the written consent of the holders of a majority of the outstanding shares of Series C-2 Preferred Stock.
A waiver of any term of Section 2.4 of this Agreement with respect to a particular transaction shall be deemed to apply to all Investors in the same fashion if such waiver does so by its terms, notwithstanding the fact that certain Investors
may nonetheless, by agreement with the Company, purchase securities in such transaction; provided, further, that, in no event shall Section 2.4 of this Agreement be amended, nor shall a waiver of Section 2.4 of this Agreement apply to the
holders of Series C-1 Preferred Stock unless the holders of at least a majority of the outstanding shares of Series C-1 Preferred Stock shall have consented to such amendment or waiver; and provided, further, that in no event shall
Section 2.4 of this Agreement be amended, nor shall a waiver of Section 2.4 of this Agreement apply to the holders of Series C-2 Preferred Stock unless the holders of at least a majority of the outstanding shares of Series C-2 Preferred
Stock shall have consented to such amendment or waiver. 
 3.8 Severability. Whenever possible, each provision of
this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement shall be held to be prohibited by or invalid under applicable law, such provision shall be ineffective only
to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Agreement. 
 3.9 Aggregation of Stock. All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for the purpose of determining the availability of any rights under
this Agreement. 
 3.10 Entire Agreement. This Agreement constitutes the full and entire understanding and
agreement between the parties with regard to the subjects hereof and thereof. 

  
 21 

 3.11 Subsequent Investors. At such time as the Company shall duly and validly
issue additional shares of Series C-1 Preferred Stock pursuant to the Series C Preferred Stock Purchase Agreement, originally dated as of April 15, 2013, as amended from time to time (the “Purchase Agreement”) to one or
more third parties in a manner approved by the Board (a “Subsequent Preferred Holder”), each such Subsequent Preferred Holder may become a party to this Agreement without the need for any additional consent, approval, signature or
other action of any party hereto by executing a counterpart signature page to this Agreement, in the form attached hereto as Exhibit A, indicating such person’s agreement to become bound by the provisions hereof and to accept the
rights and obligations hereunder (upon the Company’s receipt of such signature page, such person shall be a “Subsequent Investor”). A Subsequent Investor shall be deemed a “New Investor” under this Agreement
for any and all purposes and shall be added to Schedule A hereto as such. In addition, holders of Series C-2 Preferred Stock may become parties to this Agreement by executing a joinder agreement to this Agreement. 

3.12 Arbitration. Any controversy between the parties hereto involving any claim arising out of or relating to the
termination of this Agreement, will be submitted to and be settled by final and binding arbitration in Santa Clara County, California, in accordance with the then current Commercial Arbitration Rules of the American Arbitration Association (the
“AAA”), and judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof. Such arbitration shall be conducted by three (3) arbitrators chosen by the Company and the Investors.
There shall be limited discovery prior to the arbitration hearing as follows: (a) exchange of witness lists and copies of documentary evidence and documents relating to or arising out of the issues to be arbitrated, (b) depositions of all
party witnesses, and (c) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the California Code of Civil Procedure, the arbitrator(s) shall be required to
provide in writing to the parties the basis for the award or order of such arbitrator(s), and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. 

3.13 Prior Agreement. Upon the effectiveness of this Agreement, the parties hereto who are parties to the Prior Agreement
hereby unconditionally waive, on behalf of themselves and all other parties thereto, any rights such parties thereto may have under the Prior Agreement. Such rights shall be superseded and replaced in their entirety by the rights granted under this
Agreement. 

  
 22 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	Good Technology Corporation
		
	By:	 	 /s/ Christy Wyatt

		 	Christy Wyatt,
		 	President and Chief Executive Officer

  

			
	Address:	 	430 N. Mary Avenue, Suite 200
		 	Sunnyvale, CA 94085

  
 23 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	INVESTORS:
	
	Riverwood Capital Partners L.P.
		
	By:	 	Riverwood Capital L.P., its general partner
		
	By:	 	Riverwood Capital GP Ltd., its general partner
		
	By:	 	 /s/ Chris Varelas

	Name:	 	Chris Varelas
	Title:	 	Managing Partner

  

			
	Address:	 	c/o Riverwood Capital Management
		 	70 Willow Road, Suite 100
		 	Menlo Park, CA 94025

  

			
	Riverwood Capital Partners (Parallel – A) L.P.
		
	By:	 	Riverwood Capital L.P., its general partner
		
	By:	 	Riverwood Capital GP Ltd., its general partner
		
	By:	 	 /s/ Chris Varelas

	Name:	 	Chris Varelas
	Title:	 	Managing Partner

  

			
	Address:	 	c/o Riverwood Capital Management
		 	70 Willow Road, Suite 100
		 	Menlo Park, CA 94025

  
 24 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	INVESTORS:
	
	Riverwood Capital Partners (Parallel – B) L.P.
		
	By:	 	Riverwood Capital L.P., its general partner
		
	By:	 	Riverwood Capital GP Ltd., its general partner
		
	By:	 	 /s/ Chris Varelas

	Name:	 	Chris Varelas
	Title:	 	Managing Partner

  

			
	Address:	 	c/o Riverwood Capital Management
		 	70 Willow Road, Suite 100
		 	Menlo Park, CA 94025

  

			
	Saints Rustic Canyon, LP
		
	By:	 	Saints Rustic Canyon LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Thomas Unterman

	Name:	 	Thomas Unterman
	Title:	 	Managing Director

  

			
	Address:	 	100 Wilshire Blvd.,
		 	Suite 200
		 	Santa Monica, CA 90401

  
 25 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	INVESTORS:
	
	Oak Investment Partners X,
	Limited Partnership
		
	By:	 	Oak Associates X, LLC,
		 	its General Partner
		
	By:	 	 /s/ Bandel L. Carano

		 	Bandel L. Carano, Managing Member

 

			
	Address:	 	525 University Avenue
		 	Suite 1300
		 	Palo Alto, CA 94301
		 	Tel: (650) 614-3700
		 	Fax: (650) 328-6345

 

			
	Oak X Affiliates Fund,
	Limited Partnership
		
	By:	 	Oak X Affiliates, LLC,
		 	its General Partner
		
	By:	 	 /s/ Bandel L. Carano

		 	Bandel L. Carano, Managing Member

 

			
	Address:	 	525 University Avenue
		 	Suite 1300
		 	Palo Alto, CA 94301
		 	Tel: (650) 614-3700
		 	Fax: (650) 328-6345

  
 26 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	INVESTORS:
	
	DRAPER FISHER JURVETSON FUND VI, L.P.
		
	By:	 	 /s/ John Fisher

	Name:	 	John Fisher
	Title:	 	Managing Director
	
	DRAPER FISHER JURVETSON PARTNERS VI, LLC
		
	By:	 	 /s/ John Fisher

	Name:	 	John Fisher
	Title:	 	Managing Member
	
	DRAPER ASSOCIATES, L.P.
		
	By:	 	 /s/ Timothy C. Draper

	Name:	 	Timothy C. Draper
	Title:	 	General Partner
	
	DRAPER ASSOCIATES RISKMASTERS FUND III, L.L.C.
		
	By:	 	 /s/ Timothy C. Draper

	Name:	 	Timothy C. Draper
	Title:	 	General Partner

  

			
	Address:	 	2882 Sand Hill Road
		 	Suite 150
		 	Menlo Park, CA 94025

  
 27 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	INVESTORS:
	
	DRAPER FISHER JURVETSON EPLANET VENTURES L.P.
		
	By:	 	 /s/ John Fisher

	Name:	 	John Fisher
	Title:	 	Managing Director
	
	DRAPER FISHER JURVETSON EPLANET VENTURES GMBH &
CO. KG
		
	By:	 	 /s/ John Fisher

	Name:	 	John Fisher
	Title:	 	Managing Director
	
	DRAPER FISHER JURVETSON EPLANET PARTNERS FUND,
LLC
		
	By:	 	 /s/ John Fisher

	Name:	 	John Fisher
	Title:	 	Managing Member

  

			
	Address:	 	2882 Sand Hill Road
		 	Suite 150
		 	Menlo Park, CA 94025

  
 28 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	INVESTORS:
	
	Draper Fisher Jurvetson Growth Fund 2006, L.P.
		
	By:	 	Draper Fisher Jurvetson Growth Fund 2006 Partners, L.P.,
		 	its General Partner
		
	By:	 	 /s/ Barry Schuler

	Name:	 	Barry Schuler
	Title:	 	Director
	
	Draper Fisher Jurvetson Partners Growth Fund 2006, LLC
		
	By:	 	 /s/ Barry Schuler

	Name:	 	Barry Schuler
	Title:	 	Authorized Member

  

			
	Address:	 	2882 Sand Hill Road
		 	Suite 150
		 	Menlo Park, CA 94025

  
 29 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	INVESTORS:
	
	Meritech Capital Partners II L.P.
		
	By:	 	Meritech Capital Associates II L.L.C.,
		 	its General Partner
		
	By:	 	Meritech Management Associates II L.L.C., a managing member
		
	By:	 	 /s/ Paul Madera

		 	Paul Madera, a managing member
	
	Meritech Capital Affiliates II L.P.
		
	By:	 	Meritech Capital Associates II L.L.C.,
		 	its General Partner
		
	By:	 	Meritech Management Associates II L.L.C., a managing member
		
	By:	 	 /s/ Paul Madera

		 	Paul Madera, a managing member
	
	MCP Entrepreneur Partners II L.P.
		
	By:	 	Meritech Capital Associates II L.L.C.,
		 	its General Partner
		
	By:	 	Meritech Management Associates II L.L.C., a managing member
		
	By:	 	 /s/ Paul Madera

		 	Paul Madera, a managing member

  

			
	Address:	 	245 Lytton Ave
		 	Palo Alto, CA 94301

  
 30 

 EXHIBIT A 

COUNTERPART SIGNATURE PAGE 
 (SEE NEXT PAGE) 

  
 31 

 IN WITNESS WHEREOF, in connection with the undersigned’s purchase of shares of
Preferred Stock of the Company (or options, warrants or other rights to acquire the same) the undersigned has executed this counterpart signature page to the Amended and Restated Investors’ Rights Agreement of Good Technology Corporation dated
February 22, 2014 (the “Agreement”) pursuant to Section 3.11 of the Agreement as of the date written below. The undersigned hereby acknowledges and agrees to be bound by the provisions of the Agreement and to accept the
rights and obligations thereunder. 
  

							
		 		 	INVESTORS:
			
		 		 	RCV SBIC, LP
				
	Dated: 03-18-14	 		 	By:	 	 /s/ Thomas G. Morris

		 		 	Name:	 	Thomas G. Morris
		 		 	Title:	 	Director, Office of Liquidation
				
		 		 	Address:	 	1000 G Street, N.W., Suite 1100
		 		 		 	Washington, D.C. 20005

  
 32Prepared by R.R. Donnelley Financial -- EX-10.2

 Exhibit 10.2 
 VISTO CORPORATION 
 1996
STOCK PLAN 
 ADOPTED ON SEPTEMBER 23,
1996 
 (AMENDED AND RESTATED ON MAY 7,
1997, AUGUST 28, 1998, FEBRUARY 12, 1999, JULY 7, 1999, SEPTEMBER 15, 1999, MAY 4, 2000, MAY 8,
2001, JUNE 28, 2001, SEPTEMBER 1, 2001, NOVEMBER 29, 2001, JANUARY 25, 2002, JULY 23,
2002, MARCH 12, 2003, MAY 8, 2003, JULY 17, 2003, FEBRUARY 10, 2004, MARCH 10, 2004, SEPTEMBER 7,
2004, MARCH 24, 2005, JULY 7, 2005, OCTOBER 5, 2005 AND FEBRUARY 1, 2006) 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page No.	 
		
	 SECTION 1. ESTABLISHMENT AND PURPOSE.
	  	 	1	  
		
	 SECTION 2. ADMINISTRATION.
	  	 	1	  
			
	 (a)
	 	 Committees of the Board of Directors.
	  	 	1	  
	 (b)
	 	 Authority of the Board of Directors.
	  	 	1	  
		
	 SECTION 3. ELIGIBILITY.
	  	 	1	  
			
	 (a)
	 	 General Rule.
	  	 	1	  
	 (b)
	 	 Ten-Percent Stockholders.
	  	 	1	  
		
	 SECTION 4. STOCK SUBJECT TO PLAN.
	  	 	2	  
			
	 (a)
	 	 Basic Limitation.
	  	 	2	  
	 (b)
	 	 Additional Shares.
	  	 	2	  
		
	 SECTION 5. TERMS AND CONDITIONS OF AWARDS OR SALES.
	  	 	2	  
			
	 (a)
	 	 Stock Purchase Agreement.
	  	 	2	  
	 (b)
	 	 Duration of Offers and Nontransferability of Rights.
	  	 	3	  
	 (c)
	 	 Purchase Price.
	  	 	3	  
	 (d)
	 	 Withholding Taxes.
	  	 	3	  
	 (e)
	 	 Restrictions on Transfer of Shares and Minimum Vesting.
	  	 	3	  
		
	 SECTION 6. TERMS AND CONDITIONS OF OPTIONS.
	  	 	3	  
			
	 (a)
	 	 Stock Option Agreement.
	  	 	3	  
	 (b)
	 	 Number of Shares.
	  	 	4	  
	 (c)
	 	 Exercise Price.
	  	 	4	  
	 (d)
	 	 Withholding Taxes.
	  	 	4	  
	 (e)
	 	 Exercisability.
	  	 	4	  
	 (f)
	 	 Basic Term.
	  	 	4	  
	 (g)
	 	 Nontransferability.
	  	 	5	  
	 (h)
	 	 Termination of Service (Except by Death).
	  	 	5	  
	 (i)
	 	 Leaves of Absence.
	  	 	5	  
	 (j)
	 	 Death of Optionee.
	  	 	5	  
	 (k)
	 	 No Rights as a Stockholder.
	  	 	6	  
	 (l)
	 	 Modification, Extension and Assumption of Options.
	  	 	6	  
	 (m)
	 	 Restrictions on Transfer of Shares and Minimum Vesting.
	  	 	6	  
		
	 SECTION 7. PAYMENT FOR SHARES.
	  	 	6	  
			
	 (a)
	 	 General Rule.
	  	 	6	  

  
 i 

							
	 (b)
	 	 Surrender of Stock.
	  	 	6	  
	 (c)
	 	 Services Rendered.
	  	 	7	  
	 (d)
	 	 Promissory Note.
	  	 	7	  
	 (e)
	 	 Exercise/Sale.
	  	 	7	  
	 (f)
	 	 Exercise/Pledge.
	  	 	7	  
		
	 SECTION 8. ADJUSTMENT OF SHARES.
	  	 	7	  
			
	 (a)
	 	 General.
	  	 	7	  
	 (b)
	 	 Mergers and Consolidations.
	  	 	8	  
	 (c)
	 	 Reservation of Rights.
	  	 	9	  
		
	 SECTION 9. SECURITIES LAW REQUIREMENTS.
	  	 	9	  
			
	 (a)
	 	 General.
	  	 	9	  
	 (b)
	 	 Financial Reports.
	  	 	9	  
		
	 SECTION 10. NO RETENTION RIGHTS.
	  	 	9	  
		
	 SECTION 11. DURATION AND AMENDMENTS.
	  	 	9	  
			
	 (a)
	 	 Term of the Plan.
	  	 	9	  
	 (b)
	 	 Right to Amend or Terminate the Plan.
	  	 	11	  
	 (c)
	 	 Effect of Amendment or Termination.
	  	 	11	  
		
	 SECTION 12. DEFINITIONS.
	  	 	11	  

  
 ii 

 VISTO CORPORATION 1996 STOCK
PLAN 
 SECTION 1. ESTABLISHMENT AND PURPOSE. 
 The purpose of the Plan is to offer selected persons an opportunity to acquire a proprietary interest in the success of the Company, or to increase such interest, by purchasing Shares of the
Company’s Stock. The Plan provides both for the direct award or sale of Shares and for the grant of Options to purchase Shares. Options granted under the Plan may include Nonstatutory Options as well as ISOs intended to qualify under
Section 422 of the Code. 
 Capitalized terms are defined in Section 12. 

SECTION 2. ADMINISTRATION. 
 (a) Committees of the Board of Directors. The Plan may be administered by one or more Committees. Each Committee shall consist of one or more members of the Board of Directors who have been
appointed by the Board of Directors. Each Committee shall have such authority and be responsible for such functions as the Board of Directors has assigned to it. If no Committee has been appointed, the entire Board of Directors shall administer the
Plan. Any reference to the Board of Directors in the Plan shall be construed as a reference to the Committee (if any) to whom the Board of Directors has assigned a particular function. 

(b) Authority of the Board of Directors. Subject to the provisions of the Plan, the Board of Directors shall have full authority
and discretion to take any actions it deems necessary or advisable for the administration of the Plan. All decisions, interpretations and other actions of the Board of Directors shall be final and binding on all Purchasers, all Optionees and all
persons deriving their rights from a Purchaser or Optionee. 
 SECTION 3. ELIGIBILITY. 

(a) General Rule. Only Employees, Outside Directors and Consultants shall be eligible for the grant of Options or the direct award
or sale of Shares. Only Employees shall be eligible for the grant of ISOs. 
 (b) Ten-Percent Stockholders. A person who
owns more than 10% of the total combined voting power of all classes of outstanding stock of the Company, its Parent or any of its Subsidiaries shall not be eligible for designation as an Optionee or Purchaser unless (i) the Exercise Price is
at least 110% of the Fair Market Value of a Share on the date of grant, (ii) the Purchase Price (if any) is at least 100% of the Fair Market Value of a Share and (iii) in the case of an ISO, such ISO by its terms is not exercisable after
the expiration of five years from the date of grant. For purposes of this Subsection (b), in determining stock ownership, the attribution rules of Section 424(d) of the Code shall be applied. 

  
 1 

 SECTION 4. STOCK SUBJECT TO PLAN. 

(a) Basic Limitation. Shares offered under the Plan may be authorized but unissued Shares or treasury Shares. The aggregate number
of Shares that may be issued under the Plan (upon exercise of Options or other rights to acquire Shares) shall not exceed 31,554,8251 Shares, subject to Subsection (b) below and Section 8. All of these Shares may be issued upon the exercise of
ISOs. The number of Shares that are subject to Options or other rights outstanding at any time under the Plan shall not exceed the number of Shares that then remain available for issuance under the Plan. The Company, during the term of the Plan,
shall at all times reserve and keep available sufficient Shares to satisfy the requirements of the Plan. 
 (b) Additional
Shares. In the event that any outstanding Option or other right for any reason expires or is canceled or otherwise terminated, the Shares allocable to the unexercised portion of such Option or other right shall again be available for the
purposes of the Plan. In the event that Shares issued under the Plan are reacquired by the Company, such Shares shall again be available for the purposes of the Plan. 
 SECTION 5. TERMS AND CONDITIONS OF AWARDS OR SALES. 
 (a) Stock Purchase
Agreement. Each award or sale of Shares under the Plan (other than upon exercise of an Option) shall be evidenced by a Stock Purchase Agreement between the Purchaser and the Company. Such award or sale shall be subject to all applicable terms
and conditions of the Plan and may be subject to any other terms and conditions which are not inconsistent with the Plan and which the Board of Directors deems appropriate for inclusion in a Stock Purchase Agreement. The provisions of the various
Stock Purchase Agreements entered into under the Plan need not be identical. 
  

	1 	Reflects the 901,250-share increase authorized by the Board of Directors on May 7, 1997, the 2-for-1 stock split approved by the Board of Directors on July 9,
1997 and effective on August 12, 1997, a 180,000-share increase authorized by the Board of Directors on August 27, 1998, a 1,100,000-share increase authorized by the Board of Directors on February 12, 1999, a 2,000,000-share increase
authorized by the Board of Directors on September 15, 1999, a 3,500,000-share increase authorized by the Board of Directors on May 4, 2000, a 25,662,514-share increase authorized by the Board of Directors on May 8, 2001, a
6,342,524-share increase authorized by the Board of Directors on June 28, 2001, a 30,629,932-share increase authorized by the Board of Directors on September 17, 2001, a 12,462,037-share decrease authorized by the Board of Directors on
January 25, 2002, the 1-for-200 stock split approved by the Board of Directors on January 20, 2003 and effective on March 12, 2003, an 8,213,379-share increase authorized by the Board of Directors on May 8, 2003, a
4,597,363-share increase authorized by the Board of Directors on July 17, 2003 (the Board originally approved a share increase of 5,025,000 shares but 427,637 of such shares were transferred on July 17, 2003 to the Company’s 2003 U.K.
Stock Plan), a 500,000-share decrease authorized by the Board of Directors on February 10, 2004 for the transfer of such shares to the Company’s 2003 U.K. Stock Plan, a 346,000-share decrease authorized by the Board of Directors on
March 10, 2004 for the transfer of such shares to the Company’s 2003 U.K. Stock Plan, a 4,433,361 share increase authorized by the Board of Directors on September 7, 2004, a 600,000-share increase authorized by the Board of Directors
on March 24, 2005 for the approval of option grants to advisory board members, a 14,650,945-share increase authorized by the Board of Directors on October 5, 2005 by applying the formula approved by the Board of Directors on July 7,
2005 (the formula produced a share increase of 17,281,366 shares but 2,030,421 of such shares were transferred on the same date to the Company’s 2003 U.K. Stock Plan and 600,000 of such shares were transferred on the same date to the
Company’s International Stock Plan) and a 400,000-share decrease authorized by the Board of Directors on February 1, 2006 for the transfer of such shares to the Company’s International Stock Plan. 

  
 2 

 (b) Duration of Offers and Nontransferability of Rights. Any right to acquire Shares
under the Plan (other than an Option) shall automatically expire if not exercised by the Purchaser within 30 days after the grant of such right was communicated to the Purchaser by the Company. Such right shall not be transferable and shall be
exercisable only by the Purchaser to whom such right was granted. 
 (c) Purchase Price. The Purchase Price of Shares to
be offered under the Plan shall not be less than 85% of the Fair Market Value of such Shares, and a higher percentage may be required by Section 3(b). Subject to the preceding sentence, the Purchase Price shall be determined by the Board of
Directors at its sole discretion. The Purchase Price shall be payable in a form described in Section 7. 
 (d)
Withholding Taxes. As a condition to the purchase of Shares, the Purchaser shall make such arrangements as the Board of Directors may require for the satisfaction of any federal, state, local or foreign withholding tax obligations that may
arise in connection with such purchase. 
 (e) Restrictions on Transfer of Shares and Minimum Vesting. Any Shares awarded
or sold under the Plan shall be subject to such special forfeiture conditions, rights of repurchase, rights of first refusal and other transfer restrictions as the Board of Directors may determine. Such restrictions shall be set forth in the
applicable Stock Purchase Agreement and shall apply in addition to any restrictions that may apply to holders of Shares generally. In the case of a Purchaser who is not an officer of the Company, an Outside Director or a Consultant, any right to
repurchase a Purchaser’s Shares at the original Purchase Price (if any) upon termination of the Purchaser’s Service shall lapse at least as rapidly as the following schedule: 

 

					
	 Anniversary of Date of Sale or Award
	  	Percentage of
Shares Vested	 
		
	 First
	  	 	20	% 
	 Second
	  	 	40	% 
	 Third
	  	 	60	% 
	 Fourth
	  	 	80	% 
	 Fifth
	  	 	100	% 

 Any such repurchase right may be exercised only within 90 days after the termination of the Purchaser’s Service for
cash or for cancellation of indebtedness incurred in purchasing the Shares. 
 SECTION 6. TERMS AND CONDITIONS OF OPTIONS. 

(a) Stock Option Agreement. Each grant of an Option under the Plan shall be evidenced by a Stock Option Agreement between the
Optionee and the Company. Such Option shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms and conditions which are not inconsistent with the Plan and which the Board of Directors deems
appropriate for inclusion in a Stock Option Agreement. The provisions of the various Stock Option Agreements entered into under the Plan need not be identical. 

  
 3 

 (b) Number of Shares. Each Stock Option Agreement shall specify the number of Shares
that are subject to the Option and shall provide for the adjustment of such number in accordance with Section 8. The Stock Option Agreement shall also specify whether the Option is an ISO or a Nonstatutory Option. 

(c) Exercise Price. Each Stock Option Agreement shall specify the Exercise Price. The Exercise Price of an ISO shall not be less
than 100% of the Fair Market Value of a Share on the date of grant, and a higher percentage may be required by Section 3(b). The Exercise Price of a Nonstatutory Option shall not be less than 85% of the Fair Market Value of a Share on the date
of grant, and a higher percentage may be required by Section 3(b). Subject to the preceding two sentences, the Exercise Price under any Option shall be determined by the Board of Directors at its sole discretion. The Exercise Price shall be
payable in a form described in Section 7. 
 (d) Withholding Taxes. As a condition to the exercise of an Option, the
Optionee shall make such arrangements as the Board of Directors may require for the satisfaction of any federal, state, local or foreign withholding tax obligations that may arise in connection with such exercise. The Optionee shall also make such
arrangements as the Board of Directors may require for the satisfaction of any federal, state, local or foreign withholding tax obligations that may arise in connection with the disposition of Shares acquired by exercising an Option. 

(e) Exercisability. Each Stock Option Agreement shall specify the date when all or any installment of the Option is to become
exercisable. In the case of an Option granted to an Optionee who is not an officer of the Company, an Outside Director or a Consultant, the Option shall become exercisable at least as rapidly as set forth in the following schedule: 

 

					
	 Anniversary of Date of Option Grant
	  	Percentage of Shares
Exercisable	 
		
	 First
	  	 	20	% 
	 Second
	  	 	40	% 
	 Third
	  	 	60	% 
	 Fourth
	  	 	80	% 
	 Fifth
	  	 	100	% 

 Subject to the preceding sentence, the exercisability provisions of any Stock Option Agreement shall be determined by the
Board of Directors at its sole discretion. 
 (f) Basic Term. The Stock Option Agreement shall specify the term of the
Option. The term shall not exceed 10 years from the date of grant, and a shorter term may be required by Section 3(b). Subject to the preceding sentence, the Board of Directors at its sole discretion shall determine when an Option is to expire.

  
 4 

 (g) Nontransferability. No Option shall be transferable by the Optionee other than by
beneficiary designation, will or the laws of descent and distribution. An Option may be exercised during the lifetime of the Optionee only by the Optionee or by the Optionee’s guardian or legal representative. No Option or interest therein may
be transferred, assigned, pledged or hypothecated by the Optionee during the Optionee’s lifetime, whether by operation of law or otherwise, or be made subject to execution, attachment or similar process. 

(h) Termination of Service (Except by Death). If an Optionee’s Service terminates for any reason other than the
Optionee’s death, then the Optionee’s Options shall expire on the earliest of the following occasions: 

(i) The expiration date determined pursuant to Subsection (f) above; 

(ii) The date three months after the termination of the Optionee’s Service for any reason other than Disability, or
such later date as the Board of Directors may determine; or 
 (iii) The date six months after the termination of
the Optionee’s Service by reason of Disability, or such later date as the Board of Directors may determine. 
 The Optionee may exercise
all or part of the Optionee’s Options at any time before the expiration of such Options under the preceding sentence, but only to the extent that such Options had become exercisable before the Optionee’s Service terminated (or became
exercisable as a result of the termination) and the underlying Shares had vested before the Optionee’s Service terminated (or vested as a result of the termination). The balance of such Options shall lapse when the Optionee’s Service
terminates. In the event that the Optionee dies after the termination of the Optionee’s Service but before the expiration of the Optionee’s Options, all or part of such Options may be exercised (prior to expiration) by the executors or
administrators of the Optionee’s estate or by any person who has acquired such Options directly from the Optionee by beneficiary designation, bequest or inheritance, but only to the extent that such Options had become exercisable before the
Optionee’s Service terminated (or became exercisable as a result of the termination) and the underlying Shares had vested before the Optionee’s Service terminated (or vested as a result of the termination). 

(i) Leaves of Absence. For purposes of Subsection (h) above, Service shall be deemed to continue while the Optionee is on a
bona fide leave of absence, if such leave was approved by the Company in writing and if continued crediting of Service for this purpose is expressly required by the terms of such leave or by applicable law (as determined by the Company). 

(j) Death of Optionee. If an Optionee dies while the Optionee is in Service, then the Optionee’s Options shall expire on the
earlier of the following dates: 
 (i) The expiration date determined pursuant to Subsection (f) above; or

 (ii) The date 12 months after the Optionee’s death, or such later date as the Board of Directors may
determine. 

  
 5 

 All or part of the Optionee’s Options may be exercised at any time before the expiration of such
Options under the preceding sentence by the executors or administrators of the Optionee’s estate or by any person who has acquired such Options directly from the Optionee by beneficiary designation, bequest or inheritance, but only to the
extent that such Options had become exercisable before the Optionee’s death or became exercisable as a result of the death and the underlying Shares had vested before the Optionee’s Service death (or vested as a result of the death). The
balance of such Options shall lapse when the Optionee dies. 
 (k) No Rights as a Stockholder. An Optionee, or a
transferee of an Optionee, shall have no rights as a stockholder with respect to any Shares covered by the Optionee’s Option until such person becomes entitled to receive such Shares by filing a notice of exercise and paying the Exercise Price
pursuant to the terms of such Option. 
 (l) Modification, Extension and Assumption of Options. Within the limitations of
the Plan, the Board of Directors may modify, extend or assume outstanding Options or may accept the cancellation of outstanding Options (whether granted by the Company or another issuer) in return for the grant of new Options for the same or a
different number of Shares and at the same or a different Exercise Price. The foregoing notwithstanding, no modification of an Option shall, without the consent of the Optionee, impair the Optionee’s rights or increase the Optionee’s
obligations under such Option. 
 (m) Restrictions on Transfer of Shares and Minimum Vesting. Any Shares issued upon
exercise of an Option shall be subject to such special forfeiture conditions, rights of repurchase, rights of first refusal and other transfer restrictions as the Board of Directors may determine. Such restrictions shall be set forth in the
applicable Stock Option Agreement and shall apply in addition to any restrictions that may apply to holders of Shares generally. In the case of an Optionee who is not an officer of the Company, an Outside Director or a Consultant, any right to
repurchase an Optionee’s Shares at the original Exercise Price upon termination of the Optionee’s Service shall lapse at least as rapidly as 20% per year over the five-year period commencing on the date of the option grant. Any such
repurchase right may be exercised for cash or for cancellation of indebtedness incurred in purchasing the Shares only within 90 days after the later of (A) the termination of the Optionee’s Service or (B) the date of the option
exercise. 
 SECTION 7. PAYMENT FOR SHARES. 
 (a) General Rule. The entire Purchase Price or Exercise Price of Shares issued under the Plan shall be payable in cash or cash equivalents at the time when such Shares are purchased, except as
otherwise provided in this Section 7. 
 (b) Surrender of Stock. To the extent that a Stock Option Agreement so
provides, payment may be made all or in part with Shares owned by the Optionee or the Optionee’s representative. Such Shares shall be surrendered to the Company in good form for transfer and

  
 6 

 
shall be valued at their Fair Market Value on the date when the Option is exercised. This Subsection (b) shall not apply to the extent that acceptance of Shares in payment of the Exercise
Price would cause the Company to recognize compensation expense with respect to the Option for financial reporting purposes. 

(c) Services Rendered. At the discretion of the Board of Directors, Shares may be awarded under the Plan in consideration of
services rendered to the Company, a Parent or a Subsidiary prior to the award. 
 (d) Promissory Note. To the extent that
a Stock Option Agreement or Stock Purchase Agreement so provides, all or a portion of the Exercise Price or Purchase Price (as the case may be) of Shares issued under the Plan may be paid with a full-recourse promissory note. The Shares shall be
pledged as security for payment of the principal amount of the promissory note and interest thereon. The interest rate payable under the terms of the promissory note shall not be less than the minimum rate, if any, required to avoid (i) the
imputation of additional interest under the Code and (ii) variable accounting under the applicable guidelines issued by the Financial Accounting Standards Board. Subject to the foregoing, the Board of Directors (at its sole discretion) shall
specify the term, interest rate, amortization requirements, if any, and other provisions of such note. 
 (e)
Exercise/Sale. To the extent that a Stock Option Agreement so provides, and if Stock is publicly traded, payment may be made all or in part by the delivery (on a form prescribed by the Company) of an irrevocable direction to a securities
broker approved by the Company to sell Shares and to deliver all or part of the sales proceeds to the Company in payment of all or part of the Exercise Price and any withholding taxes. 

(f) Exercise/Pledge. To the extent that a Stock Option Agreement so provides, and if Stock is publicly traded, payment may be made
all or in part by the delivery (on a form prescribed by the Company) of an irrevocable direction to pledge Shares to a securities broker or lender approved by the Company, as security for a loan, and to deliver all or part of the loan proceeds to
the Company in payment of all or part of the Exercise Price and any withholding taxes. 
 (g) Other Forms of Payment. At
the discretion of the Board of Directors, the Purchase Price or Exercise Price of Shares issued under the Plan may be paid in any other form permitted by the Delaware General Corporation Law, as amended. 

SECTION 8. ADJUSTMENT OF SHARES. 
 (a) General. In the event of a subdivision of the outstanding Stock, a declaration of a dividend payable in Shares or a combination or consolidation of the outstanding Stock into a lesser number of
Shares, corresponding adjustments shall automatically be made in each of (i) the number of Shares available for future grants under Section 4, (ii) the number of Shares covered by each outstanding Option and (iii) the Exercise
Price under each outstanding Option. In the event of a declaration of an extraordinary dividend payable in a form other than Shares in an amount that has a material effect on the Fair Market Value of the Stock, a recapitalization, a

  
 7 

 
spin-off, a reclassification or a similar occurrence, the Board of Directors at its sole discretion may make appropriate adjustments in one or more of (i) the number of Shares available for
future grants under Section 4, (ii) the number of Shares covered by each outstanding Option or (iii) the Exercise Price under each outstanding Option. 
 (b) Mergers and Consolidations. In the event that the Company is a party to a merger or consolidation, all outstanding Options shall be subject to the agreement of merger or consolidation, which
does not have to provide that all outstanding Options (or a portion thereof) be treated in an identical manner. Such agreement, without the Optionees’ consent, may provide for one or more of the following: 

(i) The continuation of any outstanding Options by the Company (if the Company is the surviving corporation). 

(ii) The assumption of the Plan and any outstanding Options by the surviving corporation or its parent in a manner that
complies with Section 424(a) of the Code (whether or not such Options are ISOs). 
 (iii) The substitution
by the surviving corporation or its parent of new options for any outstanding Options in a manner that complies with Section 424(a) of the Code (whether or not such Options are ISOs). 

(iv) Full exercisability of any outstanding Options and full vesting of the Shares subject to such Options, followed by
the cancellation of such Options. The full exercisability of any Options and full vesting of the Shares subject to such Options may be contingent on the closing of such merger or consolidation. The Optionees shall be able to exercise such Options
during a period of not less than five full business days preceding the closing date of such merger or consolidation, unless (A) a shorter period is required to permit a timely closing of such merger or consolidation and (B) such shorter
period still offers the Optionees a reasonable opportunity to exercise such Options. Any exercise of such Options during such period may be contingent on the closing of such merger or consolidation. 

(v) The cancellation of any outstanding Options and a payment to the Optionees equal to the excess of (A) the Fair
Market Value of the Shares subject to such Options (whether or not such Options are then exercisable or such Shares are then vested) as of the closing date of such merger or consolidation over (B) their Exercise Price. Such payment shall be
made in the form of cash, cash equivalents, or securities of the surviving corporation or its parent with a Fair Market Value equal to the required amount. Such payment may be made in installments and may be deferred until the date or dates when
such Options would have become exercisable or such Shares would have vested. Such payment may be subject to vesting based on the Optionee’s continuing Service, provided that the vesting schedule shall not be less favorable to the Optionee than
the schedule under which such Options would have become exercisable or such Shares would have vested. If the Exercise Price of the Shares subject to such Options exceeds 

  
 8 

 
the Fair Market Value of such Shares, then such Options may be cancelled without making a payment to the Optionees. For purposes of this Paragraph (v), the Fair Market Value of any security
shall be determined without regard to any vesting conditions that may apply to such security. 
 (c) Reservation of
Rights. Except as provided in this Section 8, an Optionee or Purchaser shall have no rights by reason of (i) any subdivision or consolidation of shares of stock of any class, (ii) the payment of any dividend or (iii) any
other increase or decrease in the number of shares of stock of any class. Any issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall not affect, and no adjustment by reason thereof
shall be made with respect to, the number or Exercise Price of Shares subject to an Option. The grant of an Option pursuant to the Plan shall not affect in any way the right or power of the Company to make adjustments, reclassifications,
reorganizations or changes of its capital or business structure, to merge or consolidate or to dissolve, liquidate, sell or transfer all or any part of its business or assets. 
 SECTION 9. SECURITIES LAW REQUIREMENTS. 
 (a) General. Shares shall
not be issued under the Plan unless the issuance and delivery of such Shares comply with (or are exempt from) all applicable requirements of law, including (without limitation) the Securities Act of 1933, as amended, the rules and regulations
promulgated thereunder, state securities laws and regulations, and the regulations of any stock exchange or other securities market on which the Company’s securities may then be traded. 

(b) Financial Reports. The Company each year shall furnish to Optionees, Purchasers and stockholders who have received Stock under
the Plan its balance sheet and income statement, unless such Optionees, Purchasers or stockholders are key Employees whose duties with the Company assure them access to equivalent information. Such balance sheet and income statement need not be
audited. 
 SECTION 10. NO RETENTION RIGHTS. 
 Nothing in the Plan or in any right or Option granted under the Plan shall confer upon the Purchaser or Optionee any right to continue in Service for any period of specific duration or interfere with or
otherwise restrict in any way the rights of the Company (or any Parent or Subsidiary employing or retaining the Purchaser or Optionee) or of the Purchaser or Optionee, which rights are hereby expressly reserved by each, to terminate his or her
Service at any time and for any reason, with or without cause. 
 SECTION 11. DURATION AND AMENDMENTS. 

(a) Term of the Plan. The Plan became effective when adopted by the Board of Directors on September 23, 1996 and was approved
by the Company’s stockholders on October 23, 1996. On May 7, 1997 the Board of Directors authorized an increase in the number of shares issuable over the term of the Plan from 1,200,000 to 2,101,250 shares, and the stockholders
approved the 901,250-share increase on May 22, 1997. The Company effected a 2-for-1 stock 

  
 9 

 
split on August 12, 1997. All share numbers prior to this date are pre-split. On August 27, 1998 the Board of Directors authorized an increase in the number of shares issuable over the
term of the Plan from 4,202,500 shares (post-split) to 4,382,500 shares. On February 12, 1999 the Board of Directors authorized an increase in the number of shares issuable over the term of the Plan from 4,382,500 shares to 5,482,500 shares.
The stockholders approved the 180,000-share increase and the 1,100,000-share increase on April 30, 1999. On July 7, 1999 the Board of Directors approved an amendment to the Plan to make certain changes to Section 5(e) and
Section 6(e) of the Plan. On September 15, 1999 the Board of Directors authorized an increase in the number of shares issuable over the term of the Plan from 5,482,500 shares to 7,482,500 shares. On May 4, 2000 the Board of Directors
authorized an increase in the number of shares issuable over the term of the Plan from 7,482,500 shares to 10,982,500 shares. The stockholders approved the 2,000,000-share increase and the 3,500,000-share increase on June 29, 2000. On
May 8, 2001 the Board of Directors authorized an increase in the number of shares issuable over the term of the Plan from 10,982,500 shares to 36,645,014 shares, and the stockholders approved the 25,662,514-share increase on May 15, 2001.
On June 28, 2001 the Board of Directors authorized an increase in the number of shares issuable over the term of the Plan from 36,645,014 shares to 42,987,538 shares. On September 17, 2001 the Board of Directors authorized an increase in
the number of shares issuable over the term of the Plan from 42,987,538 shares to 73,617,470 shares, and the stockholders approved the 30,629,932-share increase on September 25, 2001. On November 29, 2001 the Board of Directors approved an
amendment to the Plan to make certain changes to Section 7(d) of the Plan. On January 25, 2002 the Board of Directors authorized a decrease in the number of shares issuable over the term of the Plan from 73,617,470 shares to 61,155,433
shares. On July 23, 2002 the Board of Directors approved an amendment to the Plan to make certain changes to Sections 6(h) and 6(j) of the Plan. On March 5, 2003 the Board of Directors approved a formula which would be used to calculate a
future increase in the authorized number of shares issuable over the term of the Plan, not to exceed 14,397,702 shares. The stockholders approved the formula for the future increase in the authorized shares issuable under the Plan on March 12,
2003. The Company effected a 1-for-200 stock split on March 12, 2003. All share numbers prior to this date are pre-split, except for the formula increase approved by the Board of Directors on March 5, 2003. On May 8, 2003 the Board of
Directors applied the formula approved on March 5, 2003 and authorized an interim increase in the number of shares issuable over the term of the Plan from 305,777 shares (post-split) to 8,519,156 shares. The stockholders approved the
8,213,379-interim share increase and the remaining increase of shares, not to exceed 6,184,323 shares on June 12, 2003. On July 17, 2003 the Board of Directors applied the formula approved on March 5, 2003 and authorized a final
increase in the number of shares issuable over the term of the Plan from 8,519,156 shares to 13,544,156 shares; however, the Board of Directors also authorized a transfer of 427,637 shares from the Plan into the newly adopted 2003 U.K. Stock Plan,
so that the authorized shares issuable under the Plan was decreased from 13,544,156 shares to 13,116,519 shares. On February 10, 2004 the Board of Directors authorized a decrease in the number of shares issuable over the term of the Plan from
13,116,519 shares to 12,616,519 shares for the transfer of such shares to the Company’s 2003 U.K. Stock Plan. On March 10, 2004 the Board of Directors authorized a decrease in the number of shares issuable over the term of the Plan from
12,616,519 shares to 12,270,519 shares for the transfer of such shares to the Company’s 2003 U.K. Stock Plan. On September 7, 2004, the Board of Directors authorized an increase in the number of shares issuable over the term of the Plan
from 12,270,519 shares to 16,703,880 shares. On 

  
 10 

 
March 24, 2005, the Board of Directors authorized an increase in the number of shares issuable over the term of the Plan from 16,703,880 shares to 17,303,880 shares. On July 7, 2005,
the Board of Directors approved a formula which would be used to calculate a future increase in the authorized number of shares issuable over the term of the Plan. The stockholders approved the formula for the future increase in the authorized
shares issuable under the Plan on July 12, 2005. On October 5, 2005, the Board of Directors applied the formula approved on July 7, 2005 and authorized a final increase in the number of shares issuable over the term of the Plan from
17,303,880 to 31,954,825 shares (the formula produced a share increase of 17,281,366 shares but 2,030,421 of such shares were transferred on the same date to the Company’s 2003 U.K. Stock Plan and 600,000 of such shares were transferred on the
same date to the Company’s International Stock Plan). On October 5, 2005, the Board of Directors amended and restated the Plan to update its terms. On February 1, 2006 the Board of Directors authorized a decrease in the number of
shares issuable over the term of the Plan by 400,000 shares from 31,954,825 shares to 31,554,825 shares for the transfer of such shares to the Company’s International Stock Plan. The Plan shall terminate automatically 10 years after the later
of (i) its adoption by the Board of Directors or (ii) the most recent increase in the number of Shares reserved under Section 4 that was approved by the Company’s stockholders. The Plan may be terminated on any earlier date
pursuant to Subsection (b) below. 
 (b) Right to Amend or Terminate the Plan. The Board of Directors may amend,
suspend or terminate the Plan at any time and for any reason; provided, however, that any amendment of the Plan which increases the number of Shares available for issuance under the Plan (except as provided in Section 8), or which materially
changes the class of persons who are eligible for the grant of ISOs, shall be subject to the approval of the Company’s stockholders. Stockholder approval shall not be required for any other amendment of the Plan. If the stockholders fail to
approve an increase in the number of Shares reserved under Section 4 within 12 months after its adoption by the Board of Directors, then any grants, exercises or sales that have already occurred in reliance on such increase shall be rescinded
and no additional grants, exercises or sales shall thereafter be made in reliance on such increase. 
 (c) Effect of
Amendment or Termination. No Shares shall be issued or sold under the Plan after the termination thereof, except upon exercise of an Option granted prior to such termination. The termination of the Plan, or any amendment thereof, shall not
affect any Share previously issued or any Option previously granted under the Plan. 
 SECTION 12. DEFINITIONS. 

(a) “Board of Directors” shall mean the Board of Directors of the Company, as constituted from time to time. 

(b) “Code” shall mean the Internal Revenue Code of 1986, as amended. 

(c) “Committee” shall mean a committee of the Board of Directors, as described in Section 2(a). 

(d) “Company” shall mean Visto Corporation, a Delaware corporation. 

  
 11 

 (e) “Consultant” shall mean a person who performs bona fide services for
the Company, a Parent or a Subsidiary as a consultant or advisor, excluding Employees and Outside Directors. 
 (f)
“Disability” shall mean that the Optionee is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment. 

(g) “Employee” shall mean any individual who is a common-law employee of the Company, a Parent or a Subsidiary.

 (h) “Exercise Price” shall mean the amount for which one Share may be purchased upon exercise of an Option,
as specified by the Board of Directors in the applicable Stock Option Agreement. 
 (i) “Fair Market Value”
shall mean the fair market value of a Share, as determined by the Board of Directors in good faith. Such determination shall be conclusive and binding on all persons. 
 (j) “ISO” shall mean an employee incentive stock option described in Section 422(b) of the Code. 
 (k) “Nonstatutory Option” shall mean a stock option not described in Sections 422(b) or 423(b) of the Code. 
 (l) “Option” shall mean an ISO or Nonstatutory Option granted under the Plan and entitling the holder to purchase Shares. 

(m) “Optionee” shall mean a person who holds an Option. 

(n) “Outside Director” shall mean a member of the Board of Directors who is not an Employee. 

(o) “Parent” shall mean any corporation (other than the Company) in an unbroken chain of corporations ending with the
Company, if each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a
Parent on a date after the adoption of the Plan shall be considered a Parent commencing as of such date. 
 (p)
“Plan” shall mean this Visto Corporation 1996 Stock Plan. 
 (q) “Purchase Price” shall mean
the consideration for which one Share may be acquired under the Plan (other than upon exercise of an Option), as specified by the Board of Directors. 
 (r) “Purchaser” shall mean a person to whom the Board of Directors has offered the right to acquire Shares under the Plan (other than upon exercise of an Option). 

  
 12 

 (s) “Service” shall mean service as an Employee, Outside Director or
Consultant. 
 (t) “Share” shall mean one share of Stock, as adjusted in accordance with Section 8 (if
applicable). 
 (u) “Stock” shall mean the Common Stock of the Company, with a par value of $.0001 per Share.

 (v) “Stock Option Agreement” shall mean the agreement between the Company and an Optionee which contains the
terms, conditions and restrictions pertaining to the Optionee’s Option. 
 (w) “Stock Purchase Agreement”
shall mean the agreement between the Company and a Purchaser who acquires Shares under the Plan which contains the terms, conditions and restrictions pertaining to the acquisition of such Shares. 

(x) “Subsidiary” means any corporation (other than the Company) in an unbroken chain of corporations beginning with the
Company, if each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation
that attains the status of a Subsidiary on a date after the adoption of the Plan shall be considered a Subsidiary commencing as of such date. 

  
 13 

 THE OPTION GRANTED PURSUANT TO THIS AGREEMENT AND THE SHARES ISSUABLE UPON THE EXERCISE THEREOF HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT
SUCH REGISTRATION IS NOT REQUIRED. 
 VISTO CORPORATION 1996 STOCK
PLAN: 
 STOCK OPTION AGREEMENT 

SECTION 1. GRANT OF OPTION. 
 (a) Option. On the terms and conditions set forth in the Notice of Stock Option Grant and this Agreement, the Company grants to the Optionee on the Date of Grant the option to purchase at the
Exercise Price the number of Shares set forth in the Notice of Stock Option Grant. The Exercise Price is agreed to be at least 100% of the Fair Market Value per Share on the Date of Grant (110% of Fair Market Value if Section 3(b) of the Plan
applies). This option is intended to be an ISO or a Nonstatutory Option, as provided in the Notice of Stock Option Grant. 
 (b)
Stock Plan and Defined Terms. This option is granted pursuant to the Plan, a copy of which the Optionee acknowledges having received. The provisions of the Plan are incorporated into this Agreement by this reference. Capitalized terms are
defined in Section 14 of this Agreement. 
 SECTION 2. RIGHT TO EXERCISE. 

(a) Exercisability. Subject to Subsections (b) and (c) below and the other conditions set forth in this Agreement, all or
part of this option may be exercised prior to its expiration at the time or times set forth in the Notice of Stock Option Grant. Shares purchased by exercising this option may be subject to the Right of Repurchase under Section 7. 

(b) $100,000 Limitation. If this Option is designated as an ISO in the Notice of Stock Option Grant, then the Optionee’s
right to exercise this option shall be deferred to the extent (and only to the extent) that this option otherwise would not be treated as an ISO by reason of the $100,000 annual limitation under Section 422(d) of the Code, except that:

 (i) The Optionee’s right to exercise this option shall not be deferred with respect to that portion of
the Shares subject to this option whose Fair Market Value as of the Date of Grant exceeds $500,000; and 
 (ii)
The Optionee’s right to exercise this option shall no longer be deferred in the event that (A) a Change in Control occurs, (B) this option is not assumed 

 
by the surviving corporation or its parent and (C) the surviving corporation or its parent does not substitute its own option for this option. 

(c) Stockholder Approval. Any other provision of this Agreement notwithstanding, no portion of this option shall be exercisable at
any time prior to the approval of the Plan by the Company’s stockholders. 
 SECTION 3. NO TRANSFER OR ASSIGNMENT OF OPTION.

 Except as otherwise provided in this Agreement, this option and the rights and privileges conferred hereby shall not be
sold, pledged or otherwise transferred (whether by operation of law or otherwise) and shall not be subject to sale under execution, attachment, levy or similar process. 
 SECTION 4. EXERCISE PROCEDURES. 
 (a) Notice of Exercise. The
Optionee or the Optionee’s representative may exercise this option by giving written notice to the Company pursuant to Section 13(c). The notice shall specify the election to exercise this option, the number of Shares for which it is being
exercised and the form of payment. The notice shall be signed by the person exercising this option. In the event that this option is being exercised by the representative of the Optionee, the notice shall be accompanied by proof (satisfactory to the
Company) of the representative’s right to exercise this option. The Optionee or the Optionee’s representative shall deliver to the Company, at the time of giving the notice, payment in a form permissible under Section 5 for the full
amount of the Purchase Price. 
 (b) Issuance of Shares. After receiving a proper notice of exercise, the Company shall
cause to be issued a certificate or certificates for the Shares as to which this option has been exercised, registered in the name of the person exercising this option (or in the names of such person and his or her spouse as community property or as
joint tenants with right of survivorship). The Company shall cause such certificate or certificates to be deposited in escrow or delivered to or upon the order of the person exercising this option. 

(c) Withholding Taxes. In the event that the Company determines that it is required to withhold any tax as a result of the
exercise of this option, the Optionee, as a condition to the exercise of this option, shall make arrangements satisfactory to the Company to enable it to satisfy all withholding requirements. The Optionee shall also make arrangements satisfactory to
the Company to enable it to satisfy any withholding requirements that may arise in connection with the vesting or disposition of Shares purchased by exercising this option. 
 SECTION 5. PAYMENT FOR STOCK. 
 (a) Cash. All or part of the Purchase
Price may be paid in cash or cash equivalents. 
 (b) Surrender of Stock. All or part of the Purchase Price may be paid
by the surrender of Shares in good form for transfer. Such Shares must have a fair market value (as determined by the Board of Directors) on the date of exercise of this option which, together with any

  
 2 

 
amount paid in another form permissible under this Section 5, is equal to the Purchase Price. The Optionee shall not surrender Shares in payment of the Exercise Price if such surrender would
cause the Company to recognize compensation expense with respect to the option for financial reporting purposes. 
 (c)
Exercise/Sale. If Stock is publicly traded, all or part of the Purchase Price and any withholding taxes may be paid by the delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker approved by the
Company to sell Shares and to deliver all or part of the sales proceeds to the Company. 
 (d) Exercise/Pledge. If Stock
is publicly traded, all or part of the Purchase Price and any withholding taxes may be paid by the delivery (on a form prescribed by the Company) of an irrevocable direction to pledge Shares to a securities broker or lender approved by the Company,
as security for a loan, and to deliver all or part of the loan proceeds to the Company. 
 SECTION 6. TERM AND EXPIRATION. 

(a) Basic Term. This option shall in any event expire on the expiration date set forth in the Notice of Stock Option Grant, which
date is 10 years after the Date of Grant (five years after the Date of Grant if this option is designated as an ISO in the Notice of Stock Option Grant and Section 3(b) of the Plan applies), 

(b) Termination of Service (Except by Death). If the Optionee’s Service terminates for any reason other than death, then this
option shall expire on the earliest of the following occasions: 
 (i) The expiration date determined pursuant
to Subsection (a) above; 
 (ii) The date three months after the termination of the Optionee’s Service
for any reason other than Disability; or 
 (iii) The date six months after the termination of the
Optionee’s Service by reason of Disability. 
 The Optionee may exercise all or part of this option at any time before its expiration under
the preceding sentence, but only to the extent that this option had become exercisable before the Optionee’s Service terminated. When the Optionee’s Service terminates, this option shall expire immediately with respect to the number of
Shares for which this option is not yet exercisable and with respect to any Restricted Shares. In the event that the Optionee dies after termination of Service but before the expiration of this option, all or part of this option may be exercised
(prior to expiration) by the executors or administrators of the Optionee’s estate or by any person who has acquired this option directly from the Optionee by beneficiary designation, bequest or inheritance, but only to the extent that this
option had become exercisable before the Optionee’s Service terminated. 
 (c) Death of the Optionee. If the
Optionee dies while in Service, then this option shall expire on the earlier of the following dates: 

  
 3 

 (i) The expiration date determined pursuant to Subsection (a) above;
or 
 (ii) The date 12 months after the Optionee’s death. 

All or part of this option may be exercised at any time before its expiration under the preceding sentence by the executors or administrators of the
Optionee’s estate or by any person who has acquired this option directly from the Optionee by beneficiary designation, bequest or inheritance, but only to the extent that this option had become exercisable before the Optionee’s death. When
the Optionee dies, this option shall expire immediately with respect to the number of Shares for which this option is not yet exercisable and with respect to any Restricted Shares. 

(d) Leaves of Absence. For any purpose under this Agreement, Service shall be deemed to continue while the Optionee is on a bona
fide leave of absence, if such leave was approved by the Company in writing and if continued crediting of Service for such purpose is expressly required by the terms of such leave or by applicable law (as determined by the Company). 

(e) Notice Concerning ISO Treatment. If this option is designated as an ISO in the Notice of Stock Option Grant, it ceases to
qualify for favorable tax treatment as an ISO to the extent it is exercised (i) more than three months after the date the Optionee ceases to be an Employee for any reason other than death or permanent and total disability (as defined in
Section 22(e)(3) of the Code), (ii) more than 12 months after the date the Optionee ceases to be an Employee by reason of such permanent and total disability or (iii) after the Optionee has been on a leave of absence for more than 90 days,
unless the Optionee’s reemployment rights are guaranteed by statute or by contract. 
 SECTION 7. RIGHT OF REPURCHASE. 

(a) Scope of Repurchase Right. Unless they have become vested in accordance with the Notice of Stock Option Grant and Subsection
(c) below, the Shares acquired under this Agreement initially shall be Restricted Shares and shall be subject to a right (but not an obligation) of repurchase by the Company. The Optionee shall not transfer, assign, encumber or otherwise
dispose of any Restricted Shares, except as provided in the following sentence. The Optionee may transfer Restricted Shares (i) by beneficiary designation, will or intestate succession or (ii) to the Optionee’s spouse, children or
grandchildren or to a trust established by the Optionee for the benefit of the Optionee or the Optionee’s spouse, children or grandchildren, provided in either case that the Transferee agrees in writing on a form prescribed by the Company to be
bound by all provisions of this Agreement. If the Optionee transfers any Restricted Shares, then this Section 7 shall apply to the Transferee to the same extent as to the Optionee. 

(b) Condition Precedent to Exercise. The Right of Repurchase shall be exercisable only during the 60-day period next following the
later of: 
 (i) The date when the Optionee’s Service terminates for any reason, with or without cause,
including (without limitation) death or disability; or 
 (ii) The date when this option was exercised by the
Optionee, the executors or administrators of the Optionee’s estate or any person who has acquired this option directly from the Optionee by bequest, inheritance or beneficiary designation. 

  
 4 

 (c) Lapse of Repurchase Right. The Right of Repurchase shall lapse with respect to
the Shares subject to this option in accordance with the vesting schedule set forth in the Notice of Stock Option Grant. The Right of Repurchase shall lapse and all of the remaining Restricted Shares shall become vested if (i) the Company is
subject to a Change in Control and (ii) the Right of Repurchase is not assigned to the entity that employs the Optionee immediately after the Change in Control or to its parent or subsidiary. Notwithstanding the foregoing, at a minimum, in the
event of a Change in Control, the Right of Repurchase shall lapse with respect to an additional number of Shares subject to this option, as if the Optionee served for an additional six (6) months of Service; in addition, at a minimum, in the
event that the Optionee is terminated from Service without Cause within six (6) months following a Change in Control, the Right of Repurchase shall lapse with respect to an additional number of Shares subject to this option, as if the Optionee
served an additional six (6) months of Service. 
 (d) Repurchase Cost. If the Company exercises the Right of
Repurchase, it shall pay the Optionee an amount equal to the Exercise Price for each of the Restricted Shares being repurchased. 
 (e) Exercise of Repurchase Right. The Right of Repurchase shall be exercisable only by written notice delivered to the Optionee prior to the expiration of the 60-day period specified in Subsection
(b) above. The notice shall set forth the date on which the repurchase is to be effected. Such date shall not be more than 30 days after the date of the notice. The certificate(s) representing the Restricted Shares to be repurchased shall,
prior to the close of business on the date specified for the repurchase, be delivered to the Company properly endorsed for transfer. The Company shall, concurrently with the receipt of such certificate(s), pay to the Optionee the purchase price
determined according to Subsection (d) above. Payment shall be made in cash or cash equivalents or by canceling indebtedness to the Company incurred by the Optionee in the purchase of the Restricted Shares. The Right of Repurchase shall
terminate with respect to any Restricted Shares for which it has not been timely exercised pursuant to this Subsection (e). 

(f) Additional Shares or Substituted Securities. In the event of the declaration of a stock dividend, the declaration of an
extraordinary dividend payable in a form other than stock, a spin-off, a stock split, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities without receipt of
consideration, any new, substituted or additional securities or other property (including money paid other than as an ordinary cash dividend) which are by reason of such transaction distributed with respect to any Restricted Shares or into which
such Restricted Shares thereby become convertible shall immediately be subject to the Right of Repurchase. Appropriate adjustments to reflect the distribution of such securities or property shall be made to the number and/or class of the Restricted
Shares. Appropriate adjustments shall also, after each such transaction, be made to the price per share to be paid upon the exercise of the Right of Repurchase in order to reflect any change in the Company’s outstanding securities effected
without receipt of consideration therefor; provided, however, that the aggregate purchase price payable for the Restricted Shares shall remain the same. 
 (g) Termination of Rights as Stockholder. If the Company makes available, at the time and place and in the amount and form provided in this Agreement, the consideration for the Restricted Shares to
be repurchased in accordance with this Section 7, then after such time the 

  
 5 

 
person from whom such Restricted Shares are to be repurchased shall no longer have any rights as a holder of such Restricted Shares (other than the right to receive payment of such consideration
in accordance with this Agreement). Such Restricted Shares shall be deemed to have been repurchased in accordance with the applicable provisions hereof, whether or not the certificate(s) therefor have been delivered as required by this Agreement.

 (h) Escrow. Upon issuance, the certificates for Restricted Shares shall be deposited in escrow with the Company to be
held in accordance with the provisions of this Agreement. Any new, substituted or additional securities or other property described in Subsection (f) above shall immediately be delivered to the Company to be held in escrow, but only to the
extent the Shares are at the time Restricted Shares. All regular cash dividends on Restricted Shares (or other securities at the time held in escrow) shall be paid directly to the Optionee and shall not be held in escrow. Restricted Shares, together
with any other assets or securities held in escrow hereunder, shall be (i) surrendered to the Company for repurchase and cancellation upon the Company’s exercise of its Right of Repurchase or Right of First Refusal or (ii) released to
the Optionee upon the Optionee’s request to the extent the Shares are no longer Restricted Shares (but not more frequently than once every six months). In any event, all Shares which have vested (and any other vested assets and securities
attributable thereto) shall be released within 60 days after the earlier of (i) the Optionee’s cessation of Service or (ii) the lapse of the Right of First Refusal. 
 SECTION 8. RIGHT OF FIRST REFUSAL. 
 Optionee or Transferee hereby agrees
that the Shares acquired pursuant to this Agreement are subject to the Company’s Right of First Refusal, as set forth in the Company’s Bylaws. 
 SECTION 9. LEGALITY OF INITIAL ISSUANCE. 
 No Shares shall be issued upon
the exercise of this option unless and until the Company has determined that: 
 (a) It and the Optionee have taken any actions
required to register the Shares under the Securities Act or to perfect an exemption from the registration requirements thereof; 

(b) Any applicable listing requirement of any stock exchange on which Stock is listed has been satisfied; and 

(c) Any other applicable provision of state or federal law has been satisfied. 
 SECTION 10. NO REGISTRATION RIGHTS. 
 The Company may, but shall not be
obligated to, register or qualify the sale of Shares under the Securities Act or any other applicable law. The Company shall not be obligated to take any affirmative action in order to cause the sale of Shares under this Agreement to comply with any
law. 

  
 6 

 SECTION 11. RESTRICTIONS ON TRANSFER. 

(a) Securities Law Restrictions. Regardless of whether the offering and sale of Shares under the Plan have been registered under
the Securities Act or have been registered or qualified under the securities laws of any state, the Company at its discretion may impose restrictions upon the sale, pledge or other transfer of such Shares (including the placement of appropriate
legends on stock certificates or the imposition of stop-transfer instructions) if, in the judgment of the Company, such restrictions are necessary or desirable in order to achieve compliance with the Securities Act, the securities laws of any state
or any other law, 
 (b) Market Stand-Off. In connection with any underwritten public offering by the Company of its
equity securities pursuant to an effective registration statement filed under the Securities Act, including the Company’s initial public offering, the Optionee shall not directly or indirectly sell, make any short sale of, loan, hypothecate,
pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer, or agree to engage in any of the foregoing transactions with respect to, any
Shares acquired under this Agreement without the prior written consent of the Company or its underwriters. Such restriction (the “Market Stand-Off’) shall be in effect for such period of time following the date of the final prospectus for
the offering as may be requested by the Company or such underwriters. In no event, however, shall such period exceed 180 days. The Market Stand-Off shall in any event terminate two years after the date of the Company’s initial public offering.
In the event of the declaration of a stock dividend, a spin-off, a stock split, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities without receipt of consideration, any
new, substituted or additional securities which are by reason of such transaction distributed with respect to any Shares subject to the Market Stand-Off, or into which such Shares thereby become convertible, shall immediately be subject to the
Market Stand-Off. In order to enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect to the Shares acquired under this Agreement until the end of the applicable stand-off period. The Company’s underwriters
shall be beneficiaries of the agreement set forth in this Subsection (b). This Subsection (b) shall not apply to Shares registered in the public offering under the Securities Act, and the Optionee shall be subject to this Subsection
(b) only if the directors and officers of the Company are subject to similar arrangements. 
 (c) Investment Intent at
Grant. The Optionee represents and agrees that the Shares to be acquired upon exercising this option will be acquired for investment, and not with a view to the sale or distribution thereof 

(d) Investment Intent at Exercise. In the event that the sale of Shares under the Plan is not registered under the Securities Act
but an exemption is available which requires an investment representation or other representation, the Optionee shall represent and agree at the time of exercise that the Shares being acquired upon exercising this option are being acquired for
investment, and not with a view to the sale or distribution thereof, and shall make such other representations as are deemed necessary or appropriate by the Company and its counsel. 

(e) Legends. All certificates evidencing Shares purchased under this Agreement shall bear the following legend: 

  
 7 

 “THE SHARES REPRESENTED HEREBY MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED OR IN
ANY MANNER DISPOSED OF, EXCEPT IN COMPLIANCE WITH THE TERMS OF A WRITTEN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO THE SHARES). SUCH AGREEMENT GRANTS TO THE COMPANY CERTAIN RIGHTS OF
FIRST REFUSAL UPON AN ATTEMPTED TRANSFER OF THE SHARES AND CERTAIN REPURCHASE RIGHTS UPON TERMINATION OF SERVICE WITH THE COMPANY. THE SECRETARY OF THE COMPANY WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH AGREEMENT TO THE HOLDER HEREOF WITHOUT
CHARGE.” 
 All certificates evidencing Shares purchased under this Agreement in an unregistered transaction shall bear the following
legend (and such other restrictive legends as are required or deemed advisable under the provisions of any applicable law): 

“THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED,
OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED “ 

(f) Removal of Legends. If, in the opinion of the Company and its counsel, any legend placed on a stock certificate representing
Shares sold under this Agreement is no longer required, the holder of such certificate shall be entitled to exchange such certificate for a certificate representing the same number of Shares but without such legend. 

(g) Administration. Any determination by the Company and its counsel in connection with any of the matters set forth in this
Section 11 shall be conclusive and binding on the Optionee and all other persons. 
 SECTION 12. ADJUSTMENT OF SHARES. 

In the event of any transaction described in Section 8(a) of the Plan, the terms of this option (including, without limitation, the
number and kind of Shares subject to this option and the Exercise Price) shall be adjusted as set forth in Section 8(a) of the Plan. In the event that the Company is a party to a merger or consolidation, this option shall be subject to the
agreement of merger or consolidation, as provided in Section 8(b) of the Plan. 
 SECTION 13. MISCELLANEOUS PROVISIONS. 

(a) Rights as a Stockholder. Neither the Optionee nor the Optionee’s representative shall have any rights as a stockholder
with respect to any Shares subject to this option until the Optionee or the Optionee’s representative becomes entitled to receive such Shares by filing a notice of exercise and paying the Purchase Price pursuant to Sections 4 and 5. 

  
 8 

 (b) No Retention Rights. Nothing in this option or in the Plan shall confer upon the
Optionee any right to continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or any Parent or Subsidiary employing or retaining the Optionee) or of the Optionee, which
rights are hereby expressly reserved by each, to terminate his or her Service at any time and for any reason, with or without cause. 
 (c) Notice. Any notice required by the terms of this Agreement shall be given in writing and shall be deemed effective upon personal delivery or upon deposit with the United States Postal Service,
by registered or certified mail, with postage and fees prepaid. Notice shall be addressed to the Company at its principal executive office and to the Optionee at the address that he or she most recently provided to the Company. 

(d) Entire Agreement. The Notice of Stock Option Grant, this Agreement and the Plan constitute the entire contract between the
parties hereto with regard to the subject matter hereof. They supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) which relate to the subject matter hereof. 

(e) Choice of Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of California, as
such laws are applied to contracts entered into and performed in such State. 
 SECTION 14. DEFINITIONS. 

(a) “Agreement” shall mean this Stock Option Agreement. 

(b) “Board of Directors” shall mean the Board of Directors of the Company, as constituted from time to time or, if a
Committee has been appointed, such Committee. 
 (c) “Cause” shall mean an Optionee’s unauthorized use or
disclosure of the confidential information or trade secrets of the Company, conviction of a felony under the laws of the United States or any state thereof, or gross negligence. 

(d) “Change in Control” shall mean: 

(i) The consummation of a merger or consolidation of the Company with or into another entity or any other corporate
reorganization, if more than 50% of the combined voting power of the continuing or surviving entity’s securities outstanding immediately after such merger, consolidation or other reorganization is owned by persons who were not stockholders of
the Company immediately prior to such merger, consolidation or other reorganization; or 
 (ii) The sale,
transfer or other disposition of all or substantially all of the Company’s assets. 
 A transaction shall not constitute a
Change in Control if its sole purpose is to change the state of the Company’s incorporation or to create a holding company that will be owned in 

  
 9 

 
substantially the same proportions by the persons who held the Company’s securities immediately before such transaction. 

(e) “Code” shall mean the Internal Revenue Code of 1986, as amended. 

(f) “Committee” shall mean a committee of the Board of Directors, as described in Section 2 of the Plan.

 (g) “Company” shall mean Visto Corporation, a Delaware corporation. 

(h) “Consultant” shall mean an individual who performs bona fide services for the Company, a Parent or a Subsidiary as a
consultant or advisor, excluding Employees and Outside Directors. 
 (i) “Date of Grant” shall mean the date
specified in the Notice of Stock Option Grant, which date shall be the later of (i) the date on which the Board of Directors resolved to grant this option or (ii) the first day of the Optionee’s Service. 

(j) “Disability” shall mean that the Optionee is unable to engage in any substantial gainful activity by reason of any
medically determinable physical or mental impairment. 
 (k) “Employee” shall mean any individual who is a
common-law employee of the Company, a Parent or a Subsidiary. 
 (l) “Exercise Price” shall mean the amount for
which one Share may be purchased upon exercise of this option, as specified in the Notice of Stock Option Grant. 
 (m)
“Fair Market Value” shall mean the fair market value of a Share, as determined by the Board of Directors in good faith. Such determination shall be conclusive and binding on all persons. 

(n) “ISO” shall mean an employee incentive stock option described in Section 422(b) of the Code. 

(o) “Nonstatutory Option” shall mean a stock option not described in Sections 422(b) or 423(b) of the Code. 

(p) “Notice of Stock Option Grant” shall mean the document so entitled to which this Agreement is attached. 

(q) “Optionee” shall mean the individual named in the Notice of Stock Option Grant. 

(r) “Outside Director” shall mean a member of the Board of Directors who is not an Employee. 

  
 10 

 (s) “Parent” shall mean any corporation (other than the Company) in an
unbroken chain of corporations ending with the Company, if each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.

 (t) “Plan” shall mean the Visto Corporation 1996 Stock Plan, as in effect on the Date of Grant. 

(u) “Purchase Price” shall mean the Exercise Price multiplied by the number of Shares with respect to which this option
is being exercised. 
 (v) “Restricted Share” shall mean a Share that is subject to the Right of Repurchase.

 (w) “Right of First Refusal” shall mean the Company’s right of first refusal described in
Section 8. 
 (x) “Right of Repurchase” shall mean the Company’s right of repurchase described in
Section 7. 
 (y) “Securities Act” shall mean the Securities Act of 1933, as amended. 

(z) “Service” shall mean service as an Employee, Outside Director or Consultant. 

(aa) “Share” shall mean one share of Stock, as adjusted in accordance with Section 8 of the Plan (if applicable).

 (bb) “Stock” shall mean the Common Stock of the Company, with a par value of $.0001 per Share. 

(cc) “Subsidiary” shall mean any corporation (other than the Company) in an unbroken chain of corporations beginning
with the Company, if each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.

 (dd) “Transferee” shall mean any person to whom the Optionee has directly or indirectly transferred any
Share acquired under this Agreement. 

  
 11 

 THE OPTION GRANTED PURSUANT TO THIS AGREEMENT AND THE SHARES ISSUABLE UPON THE EXERCISE THEREOF HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT
SUCH REGISTRATION IS NOT REQUIRED. 
 VISTO CORPORATION 1996 STOCK
PLAN: 
 STOCK OPTION AGREEMENT 

SECTION 1. GRANT OF OPTION. 
 (a) Option. On the terms and conditions set forth in the Notice of Stock Option Grant and this Agreement, the Company grants to the Optionee on the Date of Grant the option to purchase at the
Exercise Price the number of Shares set forth in the Notice of Stock Option Grant. The Exercise Price is agreed to be at least 100% of the Fair Market Value per Share on the Date of Grant (110% of Fair Market Value if Section 3(b) of the Plan
applies). This option is intended to be an ISO or a Nonstatutory Option, as provided in the Notice of Stock Option Grant. 
 (b)
Stock Plan and Defined Terms. This option is granted pursuant to the Plan, a copy of which the Optionee acknowledges having received. The provisions of the Plan are incorporated into this Agreement by this reference. Capitalized terms are
defined in Section 14 of this Agreement. 
 SECTION 2. RIGHT TO EXERCISE. 

(a) Exercisability. Subject to Subsections (b) and (c) below and the other conditions set forth in this Agreement, all or
part of this option may be exercised prior to its expiration at the time or times set forth in the Notice of Stock Option Grant. Shares purchased by exercising this option may be subject to the Right of Repurchase under Section 7. 

(b) $100,000 Limitation. If this Option is designated as an ISO in the Notice of Stock Option Grant, then the Optionee’s
right to exercise this option shall be deferred to the extent (and only to the extent) that this option otherwise would not be treated as an ISO by reason of the $100,000 annual limitation under Section 422(d) of the Code, except that:

 (i) The Optionee’s right to exercise this option shall not be deferred with respect to that portion of
the Shares subject to this option whose Fair Market Value as of the Date of Grant exceeds $500,000; and 
 (ii)
The Optionee’s right to exercise this option shall no longer be deferred in the event that (A) a Change in Control occurs, (B) this option is not assumed 

  
 1 

 
by the surviving corporation or its parent and (C) the surviving corporation or its parent does not substitute its own option for this option. 

(c) Stockholder Approval. Any other provision of this Agreement notwithstanding, no portion of this option shall be exercisable at
any time prior to the approval of the Plan by the Company’s stockholders. 
 SECTION 3. NO TRANSFER OR ASSIGNMENT OF OPTION.

 Except as otherwise provided in this Agreement, this option and the rights and privileges conferred hereby shall not be
sold, pledged or otherwise transferred (whether by operation of law or otherwise) and shall not be subject to sale under execution, attachment, levy or similar process. 
 SECTION 4. EXERCISE PROCEDURES. 
 (a) Notice of Exercise. The
Optionee or the Optionee’s representative may exercise this option by giving written notice to the Company pursuant to Section 13(c). The notice shall specify the election to exercise this option, the number of Shares for which it is being
exercised and the form of payment. The notice shall be signed by the person exercising this option. In the event that this option is being exercised by the representative of the Optionee, the notice shall be accompanied by proof (satisfactory to the
Company) of the representative’s right to exercise this option. The Optionee or the Optionee’s representative shall deliver to the Company, at the time of giving the notice, payment in a form permissible under Section 5 for the full
amount of the Purchase Price. 
 (b) Issuance of Shares. After receiving a proper notice of exercise, the Company shall
cause to be issued a certificate or certificates for the Shares as to which this option has been exercised, registered in the name of the person exercising this option (or in the names of such person and his or her spouse as community property or as
joint tenants with right of survivorship). The Company shall cause such certificate or certificates to be deposited in escrow or delivered to or upon the order of the person exercising this option. 

(c) Withholding Taxes. In the event that the Company determines that it is required to withhold any tax as a result of the
exercise of this option, the Optionee, as a condition to the exercise of this option, shall make arrangements satisfactory to the Company to enable it to satisfy all withholding requirements. The Optionee shall also make arrangements satisfactory to
the Company to enable it to satisfy any withholding requirements that may arise in connection with the vesting or disposition of Shares purchased by exercising this option. 
 SECTION 5. PAYMENT FOR STOCK. 
 (a) Cash. All or part of the Purchase
Price may be paid in cash or cash equivalents. 

  
 2 

 (b) Surrender of Stock. All or part of the Purchase Price may be paid by the
surrender of Shares in good form for transfer. Such Shares must have a fair market value (as determined by the Board of Directors) on the date of exercise of this option which, together with any amount paid in another form permissible under this
Section 5, is equal to the Purchase Price. The Optionee shall not surrender Shares in payment of the Exercise Price if such surrender would cause the Company to recognize compensation expense with respect to the option for financial reporting
purposes. 
 (c) Promissory Note. All or a portion of the Purchase Price may be paid with a full-recourse promissory
note. The par value of the Shares, if newly issued, shall be paid in cash or cash equivalents. The Shares acquired by exercising this option shall be pledged as security for payment of the principal amount of the promissory note and interest
thereon. The interest rate payable under the terms of the promissory note shall not be less than the minimum rate, if any, required to avoid (i) the imputation of additional interest under the Code and (ii) variable accounting under the
applicable guidelines issued by the Financial Accounting Standards Board. Subject to the foregoing, the Board of Directors (at its sole discretion) shall specify the term, interest rate, amortization requirements, if any, and other provisions of
such note. 
 (d) Exercise/Sale. If Stock is publicly traded, all or part of the Purchase Price and any withholding taxes
may be paid by the delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker approved by the Company to sell Shares and to deliver all or part of the sales proceeds to the Company. 

(e) Exercise/Pledge. If Stock is publicly traded, all or part of the Purchase Price and any withholding taxes may be paid by the
delivery (on a form prescribed by the Company) of an irrevocable direction to pledge Shares to a securities broker or lender approved by the Company, as security for a loan, and to deliver all or part of the loan proceeds to the Company. 

SECTION 6. TERM AND EXPIRATION. 
 (a) Basic Term. This option shall in any event expire on the expiration date set forth in the Notice of Stock Option Grant, which date is 10 years after the Date of Grant (five years after the Date
of Grant if this option is designated as an ISO in the Notice of Stock Option Grant and Section 3(b) of the Plan applies). 

(b) Termination of Service (Except by Death). If the Optionee’s Service terminates for any reason other than death, then this
option shall expire on the earliest of the following occasions: 
 (i) The expiration date determined pursuant
to Subsection (a) above; 
 (ii) The date three months after the termination of the Optionee’s Service
for any reason other than Disability; or 
 (iii) The date six months after the termination of the
Optionee’s Service by reason of Disability. 

  
 3 

 The Optionee may exercise all or part of this option at any time before its expiration under the preceding
sentence, but only to the extent that this option had become exercisable before the Optionee’s Service terminated. When the Optionee’s Service terminates, this option shall expire immediately with respect to the number of Shares for which
this option is not yet exercisable and with respect to any Restricted Shares. In the event that the Optionee dies after termination of Service but before the expiration of this option, all or part of this option may be exercised (prior to
expiration) by the executors or administrators of the Optionee’s estate or by any person who has acquired this option directly from the Optionee by beneficiary designation, bequest or inheritance, but only to the extent that this option had
become exercisable before the Optionee’s Service terminated. 
 (c) Death of the Optionee. If the Optionee dies
while in Service, then this option shall expire on the earlier of the following dates: 
 (i) The expiration
date determined pursuant to Subsection (a) above; or 
 (ii) The date 12 months after the Optionee’s
death. 
 All or part of this option may be exercised at any time before its expiration under the preceding sentence by the executors or
administrators of the Optionee’s estate or by any person who has acquired this option directly from the Optionee by beneficiary designation, bequest or inheritance, but only to the extent that this option had become exercisable before the
Optionee’s death. When the Optionee dies, this option shall expire immediately with respect to the number of Shares for which this option is not yet exercisable and with respect to any Restricted Shares. 

(d) Leaves of Absence. For any purpose under this Agreement, Service shall be deemed to continue while the Optionee is on a bona
fide leave of absence, if such leave was approved by the Company in writing and if continued crediting of Service for such purpose is expressly required by the terms of such leave or by applicable law (as determined by the Company). 

(e) Notice Concerning ISO Treatment. If this option is designated as an ISO in the Notice of Stock Option Grant, it ceases to
qualify for favorable tax treatment as an ISO to the extent it is exercised (i) more than three months after the date the Optionee ceases to be an Employee for any reason other than death or permanent and total disability (as defined in
Section 22(e)(3) of the Code), (ii) more than 12 months after the date the Optionee ceases to be an Employee by reason of such permanent and total disability or (iii) after the Optionee has been on a leave of absence for more than 90
days, unless the Optionee’s reemployment rights are guaranteed by statute or by contract. 
 SECTION 7. RIGHT OF REPURCHASE.

 (a) Scope of Repurchase Right. Unless they have become vested in accordance with the Notice of Stock Option Grant
and Subsection (c) below, the Shares acquired under this Agreement initially shall be Restricted Shares and shall be subject to a right (but not an obligation) of repurchase by the Company. The Optionee shall not transfer, assign, encumber or

  
 4 

 
otherwise dispose of any Restricted Shares, except as provided in the following sentence. The Optionee may transfer Restricted Shares (i) by beneficiary designation, will or intestate
succession or (ii) to the Optionee’s spouse, children or grandchildren or to a trust established by the Optionee for the benefit of the Optionee or the Optionee’s spouse, children or grandchildren, provided in either case that the
Transferee agrees in writing on a form prescribed by the Company to be bound by all provisions of this Agreement. If the Optionee transfers any Restricted Shares, then this Section 7 shall apply to the Transferee to the same extent as to the
Optionee. 
 (b) Condition Precedent to Exercise. The Right of Repurchase shall be exercisable only during the 60-day
period next following the later of: 
 (i) The date when the Optionee’s Service terminates for any reason,
with or without cause, including (without limitation) death or disability; or 
 (ii) The date when this option
was exercised by the Optionee, the executors or administrators of the Optionee’s estate or any person who has acquired this option directly from the Optionee by bequest, inheritance or beneficiary designation. 

(c) Lapse of Repurchase Right. The Right of Repurchase shall lapse with respect to the Shares subject to this option in accordance
with the vesting schedule set forth in the Notice of Stock Option Grant. The Right of Repurchase shall lapse and all of the remaining Restricted Shares shall become vested if (i) the Company is subject to a Change in Control before the
Optionee’s Service terminates and (ii) the Right of Repurchase is not assigned to the entity that employs the Optionee immediately after the Change in Control or to its parent or subsidiary or (iii) the Optionee is subject to an
Involuntary Termination within twelve (12) months following the Change in Control. 
 (d) Repurchase Cost. If the
Company exercises the Right of Repurchase, it shall pay the Optionee an amount equal to the Exercise Price for each of the Restricted Shares being repurchased. 
 (e) Exercise of Repurchase Right. The Right of Repurchase shall be exercisable only by written notice delivered to the Optionee prior to the expiration of the 60-day period specified in Subsection
(b) above. The notice shall set forth the date on which the repurchase is to be effected. Such date shall not be more than 30 days after the date of the notice. The certificate(s) representing the Restricted Shares to be repurchased shall,
prior to the close of business on the date specified for the repurchase, be delivered to the Company properly endorsed for transfer. The Company shall, concurrently with the receipt of such certificate(s), pay to the Optionee the purchase price
determined according to Subsection (d) above. Payment shall be made in cash or cash equivalents or by canceling indebtedness to the Company incurred by the Optionee in the purchase of the Restricted Shares. The Right of Repurchase shall
terminate with respect to any Restricted Shares for which it has not been timely exercised pursuant to this Subsection (e). 

  
 5 

 (f) Additional Shares or Substituted Securities. In the event of the declaration of a
stock dividend, the declaration of an extraordinary dividend payable in a form other than stock, a spin-off, a stock split, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding
securities without receipt of consideration, any new, substituted or additional securities or other property (including money paid other than as an ordinary cash dividend) which are by reason of such transaction distributed with respect to any
Restricted Shares or into which such Restricted Shares thereby become convertible shall immediately be subject to the Right of Repurchase. Appropriate adjustments to reflect the distribution of such securities or property shall be made to the number
and/or class of the Restricted Shares. Appropriate adjustments shall also, after each such transaction, be made to the price per share to be paid upon the exercise of the Right of Repurchase in order to reflect any change in the Company’s
outstanding securities effected without receipt of consideration therefor; provided, however, that the aggregate purchase price payable for the Restricted Shares shall remain the same. 

(g) Termination of Rights as Stockholder. If the Company makes available, at the time and place and in the amount and form
provided in this Agreement, the consideration for the Restricted Shares to be repurchased in accordance with this Section 7, then after such time the person from whom such Restricted Shares are to be repurchased shall no longer have any rights
as a holder of such Restricted Shares (other than the right to receive payment of such consideration in accordance with this Agreement). Such Restricted Shares shall be deemed to have been repurchased in accordance with the applicable provisions
hereof, whether or not the certificate(s) therefor have been delivered as required by this Agreement. 
 (h) Escrow. Upon
issuance, the certificates for Restricted Shares shall be deposited in escrow with the Company to be held in accordance with the provisions of this Agreement. Any new, substituted or additional securities or other property described in Subsection
(f) above shall immediately be delivered to the Company to be held in escrow, but only to the extent the Shares are at the time Restricted Shares. All regular cash dividends on Restricted Shares (or other securities at the time held in escrow)
shall be paid directly to the Optionee and shall not be held in escrow. Restricted Shares, together with any other assets or securities held in escrow hereunder, shall be (i) surrendered to the Company for repurchase and cancellation upon the
Company’s exercise of its Right of Repurchase or Right of First Refusal or (ii) released to the Optionee upon the Optionee’s request to the extent the Shares are no longer Restricted Shares (but not more frequently than once every six
months). In any event, all Shares which have vested (and any other vested assets and securities attributable thereto) shall be released within 60 days after the earlier of (i) the Optionee’s cessation of Service or (ii) the lapse of
the Right of First Refusal. 
 SECTION 8. RIGHT OF FIRST REFUSAL. 

Optionee or Transferee hereby agrees that the Shares acquired pursuant to this Agreement are subject to the Company’s Right of First
Refusal, as set forth in the Company’s Bylaws. 

  
 6 

 SECTION 9. LEGALITY OF INITIAL ISSUANCE. 

No Shares shall be issued upon the exercise of this option unless and until the Company has determined that: 

(a) It and the Optionee have taken any actions required to register the Shares under the Securities Act or to perfect an exemption from
the registration requirements thereof; 
 (b) Any applicable listing requirement of any stock exchange on which Stock is listed
has been satisfied; and 
 (c) Any other applicable provision of state or federal law has been satisfied. 

SECTION 10. NO REGISTRATION RIGHTS. 
 The Company may, but shall not be obligated to, register or qualify the sale of Shares under the Securities Act or any other applicable law. The Company shall not be obligated to take any affirmative
action in order to cause the sale of Shares under this Agreement to comply with any law. 
 SECTION 11. RESTRICTIONS ON TRANSFER.

 (a) Securities Law Restrictions. Regardless of whether the offering and sale of Shares under the Plan have been
registered under the Securities Act or have been registered or qualified under the securities laws of any state, the Company at its discretion may impose restrictions upon the sale, pledge or other transfer of such Shares (including the placement of
appropriate legends on stock certificates or the imposition of stop-transfer instructions) if, in the judgment of the Company, such restrictions are necessary or desirable in order to achieve compliance with the Securities Act, the securities laws
of any state or any other law. 
 (b) Market Stand-Off. In connection with any underwritten public offering by the
Company of its equity securities pursuant to an effective registration statement filed under the Securities Act, including the Company’s initial public offering, the Optionee shall not directly or indirectly sell, make any short sale of, loan,
hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer, or agree to engage in any of the foregoing transactions with
respect to, any Shares acquired under this Agreement without the prior written consent of the Company or its underwriters. Such restriction (the “Market Stand-Off”) shall be in effect for such period of time following the date of the final
prospectus for the offering as may be requested by the Company or such underwriters. In no event, however, shall such period exceed 180 days. The Market Stand-Off shall in any event terminate two years after the date of the Company’s initial
public offering. In the event of the declaration of a stock dividend, a spin-off, a stock split, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities without receipt of
consideration, any new, substituted or additional securities which are by reason of such transaction distributed with respect to any Shares subject to the Market Stand-Off, or into which such Shares thereby become

  
 7 

 
convertible, shall immediately be subject to the Market Stand-Off. In order to enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect to the Shares acquired
under this Agreement until the end of the applicable stand-off period. The Company’s underwriters shall be beneficiaries of the agreement set forth in this Subsection (b). This Subsection (b) shall not apply to Shares registered in the
public offering under the Securities Act, and the Optionee shall be subject to this Subsection (b) only if the directors and officers of the Company are subject to similar arrangements. 

(c) Investment Intent at Grant. The Optionee represents and agrees that the Shares to be acquired upon exercising this option will
be acquired for investment, and not with a view to the sale or distribution thereof. 
 (d) Investment Intent at
Exercise. In the event that the sale of Shares under the Plan is not registered under the Securities Act but an exemption is available which requires an investment representation or other representation, the Optionee shall represent and agree at
the time of exercise that the Shares being acquired upon exercising this option are being acquired for investment, and not with a view to the sale or distribution thereof, and shall make such other representations as are deemed necessary or
appropriate by the Company and its counsel. 
 (e) Legends. All certificates evidencing Shares purchased under this
Agreement shall bear the following legend: 
 “THE SHARES REPRESENTED HEREBY MAY NOT BE SOLD, ASSIGNED, TRANSFERRED,
ENCUMBERED OR IN ANY MANNER DISPOSED OF, EXCEPT IN COMPLIANCE WITH THE TERMS OF A WRITTEN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO THE SHARES). SUCH AGREEMENT GRANTS TO THE COMPANY
CERTAIN RIGHTS OF FIRST REFUSAL UPON AN ATTEMPTED TRANSFER OF THE SHARES AND CERTAIN REPURCHASE RIGHTS UPON TERMINATION OF SERVICE WITH THE COMPANY. THE SECRETARY OF THE COMPANY WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH AGREEMENT TO THE
HOLDER HEREOF WITHOUT CHARGE.” 
 All certificates evidencing Shares purchased under this Agreement in an unregistered transaction shall
bear the following legend (and such other restrictive legends as are required or deemed advisable under the provisions of any applicable law): 
 “THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF
UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.” 

  
 8 

 (f) Removal of Legends. If, in the opinion of the Company and its counsel, any legend
placed on a stock certificate representing Shares sold under this Agreement is no longer required, the holder of such certificate shall be entitled to exchange such certificate for a certificate representing the same number of Shares but without
such legend. 
 (g) Administration. Any determination by the Company and its counsel in connection with any of the
matters set forth in this Section 11 shall be conclusive and binding on the Optionee and all other persons. 
 SECTION 12. ADJUSTMENT OF
SHARES. 
 In the event of any transaction described in Section 8(a) of the Plan, the terms of this option (including,
without limitation, the number and kind of Shares subject to this option and the Exercise Price) shall be adjusted as set forth in Section 8(a) of the Plan, In the event that the Company is a party to a merger or consolidation, this option
shall be subject to the agreement of merger or consolidation, as provided in Section 8(b) of the Plan. 
 SECTION 13. MISCELLANEOUS
PROVISIONS. 
 (a) Rights as a Stockholder. Neither the Optionee nor the Optionee’s representative shall have any
rights as a stockholder with respect to any Shares subject to this option until the Optionee or the Optionee’s representative becomes entitled to receive such Shares by filing a notice of exercise and paying the Purchase Price pursuant to
Sections 4 and 5. 
 (b) No Retention Rights. Nothing in this option or in the Plan shall confer upon the Optionee any
right to continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or any Parent or Subsidiary employing or retaining the Optionee) or of the Optionee, which rights are
hereby expressly reserved by each, to terminate his or her Service at any time and for any reason, with or without cause. 
 (c)
Notice. Any notice required by the terms of this Agreement shall be given in writing and shall be deemed effective upon personal delivery or upon deposit with the United States Postal Service, by registered or certified mail, with postage and
fees prepaid. Notice shall be addressed to the Company at its principal executive office and to the Optionee at the address that he or she most recently provided to the Company. 

(d) Entire Agreement. The Notice of Stock Option Grant, this Agreement and the Plan constitute the entire contract between the
parties hereto with regard to the subject matter hereof. They supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) which relate to the subject matter hereof. 

(e) Choice of Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of California, as
such laws are applied to contracts entered into and performed in such State. 

  
 9 

 SECTION 14. DEFINITIONS. 
 (a) “Agreement” shall mean this Stock Option Agreement. 
 (b)
“Board of Directors” shall mean the Board of Directors of the Company, as constituted from time to time or, if a Committee has been appointed, such Committee. 
 (c) “Cause” shall mean: (a) any breach of the Proprietary Information and Assignment of Inventions Agreement between the Optionee and the Company; (b) conviction of, or a plea
of “guilty” or “no contest” to, a felony under the laws of the United States or any State; (c) threats or acts of violence or unlawful harassment directed against any present, former or prospective employee, independent
contractor, vendor, customer or business partner of the Company; (d) gross negligence in the performance of duties assigned by the Company; (e) the commission of any act of fraud, embezzlement or dishonesty; or (f) continued failure
to perform reasonable and lawful duties assigned by the Company after receiving written notice from the Company and given a period of 30 days to cure such failure, to the extent such failure is curable. The foregoing, however, is not an exclusive
list of all acts or omissions that the Company may consider as grounds for discharging the Optionee without Cause. 
 (d)
“Change in Control” shall mean: 
 (i) The consummation of a merger or consolidation of the
Company with or into another entity or any other corporate reorganization, if more than 50% of the combined voting power of the continuing or surviving entity’s securities outstanding immediately after such merger, consolidation or other
reorganization is owned by persons who were not stockholders of the Company immediately prior to such merger, consolidation or other reorganization; or 
 (ii) The sale, transfer or other disposition of all or substantially all of the Company’s assets. 
 A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company’s incorporation or to create a holding company that will be owned in substantially the
same proportions by the persons who held the Company’s securities immediately before such transaction. 
 (e)
“Code” shall mean the Internal Revenue Code of 1986, as amended. 
 (f) “Committee” shall mean
a committee of the Board of Directors, as described in Section 2 of the Plan. 
 (g) “Company” shall mean
Visto Corporation, a Delaware corporation. 
 (h) “Consultant” shall mean an individual who performs bona fide
services for the Company, a Parent or a Subsidiary as a consultant or advisor, excluding Employees and Outside Directors. 

  
 10 

 (i) “Date of Grant” shall mean the date specified in the Notice of Stock
Option Grant, which date shall be the later of (i) the date on which the Board of Directors resolved to grant this option or (ii) the first day of the Optionee’s Service. 

(j) “Disability” shall mean that the Optionee is unable to engage in any substantial gainful activity by reason of any
medically determinable physical or mental impairment. 
 (k) “Employee” shall mean any individual who is a
common-law employee of the Company, a Parent or a Subsidiary. 
 (1) “Exercise Price” shall mean the amount for
which one Share may be purchased upon exercise of this option, as specified in the Notice of Stock Option Grant. 
 (m)
“Fair Market Value” shall mean the fair market value of a Share, as determined by the Board of Directors in good faith. Such determination shall be conclusive and binding on all persons. 

(n) “Involuntary Termination” shall mean (i) a termination by the Company without Cause or (ii) the
Optionee’s resignation following a change in the Optionee’s position with the Company that materially reduces the Optionee’s level of responsibility, a reduction in the Optionee’s total compensation (including incentive bonuses)
of at least 15% unless such reduction is an across-the-board reduction for officers of the Company or a relocation of the Optionee’s place of employment by more than fifty (50) miles, provided and only if such change, reduction or
relocation is effected by the Company without the Optionee’s consent. 
 (o) “ISO” shall mean an employee
incentive stock option described in Section 422(b) of the Code. 
 (p) “Nonstatutory Option” shall mean a
stock option not described in Sections 422(b) or 423(b) of the Code. 
 (q) “Notice of Stock Option Grant”
shall mean the document so entitled to which this Agreement is attached. 
 (r) “Optionee” shall mean the
individual named in the Notice of Stock Option Grant. 
 (s) “Outside Director” shall mean a member of the
Board of Directors who is not an Employee. 
 (t) “Parent” shall mean any corporation (other than the Company)
in an unbroken chain of corporations ending with the Company, if each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such
chain. 

  
 11 

 (u) “Plan” shall mean the Visto Corporation 1996 Stock Plan, as in effect
on the Date of Grant. 
 (v) “Purchase Price” shall mean the Exercise Price multiplied by the number of Shares
with respect to which this option is being exercised. 
 (w) “Restricted Share” shall mean a Share that is
subject to the Right of Repurchase. 
 (x) “Right of First Refusal” shall mean the Company’s right of
first refusal described in Section 8. 
 (y) “Right of Repurchase” shall mean the Company’s right of
repurchase described in Section 7. 
 (z) “Securities Act” shall mean the Securities Act of 1933, as
amended. 
 (aa) “Service” shall mean service as an Employee, Outside Director or Consultant. 

(bb) “Share” shall mean one share of Stock, as adjusted in accordance with Section 8 of the Plan (if applicable).

 (cc) “Stock” shall mean the Common Stock of the Company, with a par value of $.0001 per Share. 

(dd) “Subsidiary” shall mean any corporation (other than the Company) in an unbroken chain of corporations beginning
with the Company, if each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.

 (ee) “Transferee” shall mean any person to whom the Optionee has directly or indirectly transferred any
Share acquired under this Agreement. 

  
 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00231-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00231-of-00352.parquet"}]]